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Obesity is a disease that increases risk of developing metabolic diseases including
insulin resistance (IR), metabolic syndrome (MS), and type 2 diabetes (T2D). Adipose
tissue expansion during obesity leads to immune cell infiltration, causing local
inflammation and disruption of lipid homeostasis. There is an association between
exposure to environmental chemicals, like p,p’-DDE, a metabolite of p,p’-DDT, and
diagnosis of obesity, dyslipidemia, IR, and prevalence of MS and T2D. DDE accumulates
in fatty tissues and has been shown to have immunomodulatory properties, affecting
macrophage and T cell populations. Potential mechanisms were studied by which DDE
could modulate adipocyte and immune cell function and facilitate an increased risk of
obesity and immune dysregulation, potentially through cyclooxygenase-2 (COX-2). 3T3L1 preadipocytes and J774A.1 macrophages were studied for the effects of DDE on
adipogenesis and macrophage reactivity, respectively. 3T3-L1 cells were induced to
differentiate to adipocytes using a sub-optimal differentiation cocktail with increasing
concentrations of DDE (0.5uM-100uM). It was determined that DDE enhanced
adipogenesis in a concentration dependent manner and the expression of adipogenic and

lipogenic genes, indicating that DDE enhances adipogenesis. In J774A.1 cells, the ability
of DDE or 10uM NS-398, a specific COX-2 inhibitor, to inhibit the production of the
prostaglandins PGE2, PGD2, PGF2α, was assessed in vitro and in a cell-free system. DDE
or NS-398 followed by immune challenge reduced cellular PG secretion and reduced PG
production in a cell free system, indicating that DDE may interfere with lipid mediator
signaling. Additionally, DDE or NS-398 exposure altered gene expression in J774A.1
cells following M1 or M2 polarization stimulus. Lastly, male C57Bl mice were exposed
to 2mg/kg DDE for 5 days and the macrophage population of the adipose stromal
vascular fraction was analyzed by flow cytometry. Adipose from DDE treated animals
contained approximately 40% F4/80+CD11b+ macrophages. These results indicate that
DDE may alter the homeostasis of adipose tissue by both enhancing adipogenesis and
altering the reactivity of the resident macrophage population in a manner that may
contribute to adipose dysfunction. These data suggest a possible mechanism by which
DDE exposure may contribute to adiposity and adipose tissue dysfunction commonly
seen in metabolic disease.
.
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ORGANOCHLORINE PESTICIDE EXPOSURE AND METABOLIC SYNDROME: A
POSSIBLE MECHANISTIC CONNECTION

1.1

Introduction
Obesity is a disease of epidemic proportions that is linked to the pathogenesis of

metabolic syndrome, cardiovascular disease (CVD), and type 2 diabetes mellitus (T2D)
and represents a lifelong health threat to affected individuals. More than two-thirds of all
US adults over the age of 20 are overweight or obese and, worldwide, 1.6 billion and 400
million adults are overweight or obese, respectively (1). Alarmingly, the incidence of
obesity has more than doubled since 1980 (2) and the rate of T2D among US adults has
more than tripled in the same time span (3). This trend is expected to continue over the
coming decades; the number of individuals with T2D in the US is expected to double by
2020, affecting as many as 1 in 3 adults by 2050 (4). Total cost estimates for T2D related
illness in the US was estimated at $174 billion in 2007 alone (5). CVD is now the leading
cause of death, accounting for approximately 30% of all cause deaths worldwide (6)
while T2D is the 7th leading cause of death in the US (7). The most commonly used index
for assessing body fat is the body mass index (BMI), which is calculated as weight in
kilograms divided by height in meters squared. Obesity is defined as having a body mass
index >30 and greatly increases the risk of CVD. Abdominal or visceral fat accumulation
is the consequence of excess nutrition in a state of physical inactivity and, relative to
1

normal weight, is significantly associated with all-cause mortality, especially when BMI
>35. Visceral adipose tissue was once dismissed as a fat storage depot, but it is now
widely regarded as an endocrine organ in its own right that is a source of hormones,
peptides, adipokines and cytokines that regulate inflammation, hunger and satiety, and
the utilization of glucose and lipids. During states of excess nutrition, it is not merely the
accumulation of fat that contributes to the pathogenesis of metabolic syndrome and
insulin resistance. Increasing adiposity is associated with a chronic, low-grade
inflammatory state that is strongly linked to the development of T2D and CVD is in part
due to the infiltration of immune cells into the visceral adipose tissue.
The intimate relationship between metabolism and immunity is not fully
understood and cannot be accurately defined using classical models of inflammation. A
new classification of ‘meta-inflammation’ or metabolically induced inflammation has
been described to better describe this relationship. The progression of disease is still
subject to debate, but it is thought that as innate immune cells infiltrate into adipose
tissue, the adipokine and cytokine secretory profile shifts towards an inflammatory state.
These mediators act both locally and systemically to reduce insulin sensitivity and
mobilize lipids and glucose, eventually leading to ectopic fat deposition in muscle and
liver and contributing to vascular injury and the initiation of an atherosclerotic plaque (8).
Until the mid-20th century, T2D was referred to as ‘adult onset’ diabetes and was
rather rare. The reason for the rise in prevalence of T2D can be attributed to a westernstyle diet combined with a sedentary lifestyle, but there is a growing body of evidence
suggesting that exogenous chemicals, particularly endocrine disrupting chemicals
(EDCs), may contribute to the development of obesity and metabolic syndrome (9). One
2

class of chemicals often implicated in this association is persistent organic pollutants
(POPs). Exposures to high concentrations of chlorinated compounds and chlorinated
pesticides, particularly polychlorinated biphenyls (PCB’s) and organochlorine (OC)
pesticides, have been consistently associated with not only increased odds of disease
status, but also increased risk of development of T2D and metabolic syndrome in people
free of disease (10). Two OC pesticides in particular, p,p’-DDE, a metabolite of DDT,
and trans-nonachlor, a component of the commercial insecticide mixture called
chlordane, are significantly associated with increased odds of T2D (10) and metabolic
syndrome (9). Though these chemicals have been banned for decades in most developed
countries, they have long half-lives and persist in the environment for many years.
Additionally, DDT is still used for vector control in regions with endemic malaria while
pesticide residues can be detected in food products and soils across the globe (11-13).
More recently, groups supporting a limited reintroduction of DDT have decried its ban,
claiming that the cost in human lives due to malarial infection outweighs the potential
risks associated with exposure (14).
Given the epidemiological data, it is important to determine if exposure is merely
associative or if there is a mechanism by which these compounds might contribute to the
development of metabolic syndrome and cardiovascular disease (CVD). While it is
unlikely that these compounds directly cause overt insulin resistance, in a state of excess
nutrition, these compounds may contribute to the disruption of normal physiological
responses in adipose or immune cells by increasing adipogenesis or by enhancing an
inflammatory response from the stromal vascular fraction (SVF) of adipose tissue.

3

1.2

Metabolic Syndrome
Metabolic syndrome is a metabolic state characterized by a cluster of signs that

are known risk factors for CVD. The World Health Organization (WHO) defines
metabolic syndrome as a state of insulin resistance, referring to diabetes, impaired
glucose tolerance and impaired fasting glucose, in combination with dyslipidemia (high
triglycerides and/or low HDL cholesterol), hypertension, central obesity, and
microalbuminuria (15, 16). Obesity, or more specifically obesity induced inflammation,
is considered to be a key component in the pathogenesis of metabolic syndrome (17, 18).
1.2.1

Adipose tissue dysfunction in obesity leads to inflammation and the
recruitment of immune cells:
Throughout our evolutionary history, humans have primarily existed in states of

feast or famine. Our ability to survive under these conditions was due to a highly
integrated and complex system designed for long term storage of energy during times of
excess and mobilization during starvation and stress. When food is plentiful, energy is
stored as glycogen in the liver, but primarily the energy is stored in the form of
triglycerides in adipocytes to be utilized during periods of energy deprivation or infection
(19). While the mechanism of fat storage was vital to survival throughout most of human
history, the shift toward sedentary, high-stress lifestyles in an environment of calorieexcess has caused this adaptation to become a maladaptive response that favors obesity
and the development of metabolic syndrome (20, 21).
Excess calorie intake promotes adipocyte hypertrophy and hyperplasia.
Hypertrophy is the expansion of mature adipocytes through nutrient uptake. Hyperplasia
occurs when mesenchymal stem cells (MCS) are recruited from the stromal vascular
4

compartment of adipose tissue and become committed to the preadipocyte lineage.
Mature adipocytes contain a single, large fat droplet that undergoes lipolysis to release
triglycerides to supply energy to peripheral tissue during periods of high energy demand.
During the post-prandial state, insulin secreted by the pancreas induces lipogenic
enzymes that synthesize triglycerides that are stored in the fat droplet (19, 22). In the
early stages of chronic nutrient excess and the progression from lean to overweight,
mature adipocytes continue to accumulate triglycerides and become hypertrophic. Over
time, hypertrophic adipocytes may undergo necrosis, causing direct recruitment of
macrophages, or they become metabolically stressed due to endoplasmic reticulum (ER)
stress, hypoxic conditions, or the accumulation of extracellular free fatty acids (FFA),
resulting in the activation of intracellular stress kinase pathways and generation of
reactive oxygen species. Intracellular inflammatory signaling pathways act in a feedback
manner to enhance inflammation, inducing the production of inflammatory cytokines like
TNFα, IL-6, and leptin, as well as monocyte chemoattractant protein 1 (MCP-1) which
enhances macrophage infiltration into adipose tissue (20, 23).
The initiation of adipose tissue inflammation is considered to have a pivotal role
in the development of metabolic syndrome. The infiltration of macrophages and immune
cells into the adipose tissue and the subsequent production of proinflammatory cytokines
by both macrophages and adipocytes likely alter adipose tissue function, leading to
systemic insulin resistance. Inflammation of the adipose tissue does not mimic acute
inflammatory processes that resolve quickly; rather, it is characterized by a long-duration
and low-amplitude inflammatory response (24). Chronic inflammation of adipose tissue
impairs proper triglyceride storage and the excess lipids are transported to peripheral
5

tissues and deposited in liver and muscle tissues. Ectopic triglyceride deposition disrupts
cellular function by interfering with mitochondrial oxidative phosphorylation and by
inducing stress signaling pathways that inhibit insulin stimulated glucose uptake, thereby
contributing to the development of insulin resistance (25, 26).
We now know that immunity and metabolism are closely connected, and linking
obesity to inflammation has caused a shift in how obesity and metabolic syndrome are
perceived. It has been suggested that temporary insulin resistance was once a survival
mechanism. Starvation and infection induce a proinflammatory, insulin resistant
condition that allows for the rapid mobilization of glucose and free fatty acids (FFAs)
needed for the brain and, in cases of infection, the provision of fuel to a population of
activated immune cells; however, this process is dysregulated in the current environment
of overnutrition (20, 27).
Immune cells are present in all tissues and serve as early detection systems to
mount a defense during infections. In lean, non-hypertrophied adipose tissue, resident
macrophages comprise approximately 5-10% of adipose tissue while the stromal vascular
fraction contains a heterogeneous population of T-cells, B-cells, neutrophils, and
dendritic cells. In a normal physiological state, resident macrophages in lean, nonhypertrophied adipose tissue are polarized towards an anti-inflammatory state, referred to
as alternatively activated, M2 macrophages and are characterized by expression of IL-10
and cell surface proteins that are involved in tissue repair and improved insulin
sensitivity. Additionally, a small subpopulation (5-15%) of CD4+ T-cells, T regulatory
(Treg) cells, appears to be very important in the control of adipose tissue inflammation
and insulin sensitivity. Tregs are critical in the suppression of inappropriate immune
6

responses in the context of autoimmunity, cancer progression, infection and inflammation
and, in one study, their depletion aggravated the metabolic function in even non-obese
mice whereas increased numbers of Tregs improved insulin sensitivity through the
production of IL-10 (28). In support of this finding, Tregs are decreased in obese adipose
tissue, but their adoptive transfer to inflamed adipose improved insulin sensitivity in
ob/ob mice (26, 29).
During diet induced obesity (DIO) adipose tissue undergoes remodeling;
angiogenesis results in increased blood flow as required by the expansion and
differentiation of adipocytes and, due to monocyte recruitment and differentiation, the
proportion of macrophage cells in the adipose rises from 5-10% in lean adipose tissue to
an estimated 30-50% of all cells (30). As macrophage infiltration progresses, a feedback
loop involving saturated fatty acids and cytokines like TNFα is established between
hypertrophic adipocytes and immune cells that drives a vicious cycle of inflammatory
changes; secretion of TNFα, IL-6, MCP-1, and leptin, an adipokine that inactivates
Tregs, is increased while anti-inflammatory compounds like adiponectin and IL-10 are
downregulated (25). The population of other innate immune cells in the stromal vascular
fraction also undergoes changes as well. One study found CD11c+ dendritic cells are
increased during the early stages of DIO and comprise a large proportion of the F4/80
positive cells of myeloid origin. These cells were found in the crown-like structures that
surround hypertrophied adipocytes in obese adipose tissue and caused the recruitment of
other CD11b and F4/80 positive macrophages, while dendritic cell-null mice had
significantly fewer adipose tissue macrophages which was reversed upon adoptive
transfer of dendritic cells (31). Nishimura et al (2009) reported increasing numbers of
7

cytotoxic CD8+ T cells, CD31+ endothelial cells, and CD11b+ F4/80+ cells after 16
weeks of high fat diet feeding, while CD4+ T helper cells and CD4+CD25+Foxp3+
Tregs were significantly reduced (26). T-cells from obese diabetic and obese nondiabetic people exhibit inflammatory profiles. However, one study using a murine model
suggests that B-cells from obese T2D (but not non-T2D) mice support a proinflammatory
Th1 cell phenotype (32). Interestingly, a recent study demonstrated that the
proinflammatory response of adipose tissue during DIO may be necessary for proper
adipose tissue expansion. The authors utilized mouse models with reduced capability for
adipose tissue-specific pro-inflammatory response to evaluate the role of local adipose
tissue inflammation in the systemic inflammation and metabolic dysfunction that occurs
during weight gain and obesity. It was found that a loss of strong pro-inflammatory
response within the adipose tissue following high fat feeding may prevent proper
remodeling of the extracellular matrix and inhibit angiogenesis. These two processes are
essential for adipogenesis and adipose tissue expansion, and loss of these functions may
lead to ectopic fat storage and delay resolution of inflammation in the adipose tissue,
contributing to chronic systemic inflammation (33). These studies suggest that adipose
tissue inflammation is a complex process involving adipose tissue remodeling that can be
initiated and propagated though changes in immune cell populations.
1.2.2

Cardiovascular disease:
Hyperglycemia and increased free fatty acid levels resulting from insulin

resistance contribute to the development of CVD by contributing to the injury process
and macrophage infiltration that would lead to the development of an atherosclerotic
plaque. Hyperglycemia has been correlated with increased risk of vascular disease (34).
8

Glucose may interfere with endothelial function in the vasculature as it is oxidized by
glucose oxidase, resulting in superoxide anions which are converted into hydrogen
peroxide which, if not acted on by catalase, can further break down into additional
reactive oxygen species capable of oxidizing lipids and other cellular constituents (35).
Increased lipolysis as a result of insulin resistance in the adipose tissue can lead to higher
circulating levels of FFA for extended periods of time. In diabetics, these concentrations
do not decline in the post-prandial state or in response to insulin (36). Elevated FFAs
may affect signal transduction and decrease nitric oxide synthase activity, reducing the
atheroprotective ability of nitric oxide by allowing for the interaction of platelets and
leukocytes with the vascular endothelium and the proliferation and migration of vascular
smooth muscle cells (37). As injury occurs to the vascular endothelium, low density
lipoprotein (LDL) particles invade the intima and are oxidized, and monocytes are
recruited to the area. Once inside the arterial intima, monocytes differentiate into
macrophages and express scavenger receptors, which allow the macrophages to
phagocytize oxidized LDL particles and cause the macrophages to assume the so-called
foam cell morphology (38, 39), starting the process of plaque formation. Necrotic
breakdown of these plaque formations is more common in the lesions of diabetics and
this necrosis is critical in the progression towards atherosclerosis. Necrosis is caused by
the uncontrolled cell death of oxidized LDL-containing macrophages and improper
clearance of these dead macrophages and their contents. In the presence of insulin
resistance (IR), the macrophages may be more susceptible to apoptosis as macrophages
have an endoplasmic reticulum stress pathway, the proapoptotic branch of the unfolded
protein response pathway, which is partially regulated by the insulin signaling pathway.
9

When insulin signaling is downregulated in the presence of insulin resistance, the
unfolded protein response-induced apoptosis mechanism is enhanced (40).
1.2.3

Link between cyclooxygenase and metabolic dysfunction:
The role of cyclooxygenases (COX) and the lipid mediators produced by these

enzymes in obesity and cardiovascular disease is a subject of debate. The COX enzyme,
also known as PGH2 synthase, has two isoforms, COX-1 and -2, which are responsible
for converting a precursor essential fatty acid, arachidonic acid (AA), to bioactive lipid
mediators known as prostaglandins (PGs). These lipid mediators include PGE2, PGD2,
PGI2, PGF2α, and thromboxane (TXA2).
There is a body of evidence that suggests a role for prostaglandins, particularly
PGE2, in the regulation of adipogenesis of preadipocytes and lipolysis in mature cells.
Fain et al (2001) found that mice heterozygous for COX-2 +/-, but not COX -1 or -2 null
mice, developed obesity when fed a high fat, high sugar diet. Fat pads from COX-2+/mice were 134% larger than COX- 2+/+ controls and 328% larger than COX-2 -/-, and
leptin secretion was elevated by 336% over controls (41). The rise in leptin secretion
could adversely affect Treg populations, as leptin has been shown to inhibit the
proliferation of this T cell population, causing a reduction in regulatory T cell numbers
and the loss of potent regulator of inflammation (42). Prostaglandin production was
significantly reduced, but not eliminated, and these mice did not develop insulin
resistance or hyperglycemia and because of this, the authors concluded that this model
did not represent obesity in T2D (41). Conversely, there is evidence that PGE2 signaling
through the prostaglandin E receptor 4 (EP4) suppresses differentiation of murine
embryonic fibroblasts and that COX-2 inhibition can enhance 3T3-L1 preadipocyte
10

differentiation when a known inhibitor of differentiation, TNFα, is added to the media
(43). A more recent study reported that 3T3-L1 cells stably transfected with either of the
COX isoforms produced greater amounts of PGE2 and were unable to commit to the
differentiation program. It was reported that COX inhibitors were unable to reverse the
suppression of adipogenesis, though this study did not use selective COX inhibitors, but
rather used indomethacin which has been reported to induce adipogenesis through a nonCOX dependent mechanism (44, 45). On the contrary, when the same group transfected
3T3-L1 cells COX-2 in the antisense direction, adipogenesis was greatly enhanced and
could be appreciably reduced by the addition of exogenous PGE2 to the cell culture media
(46). This is likely due to the fact that PGE2 is a potent stimulator of lipolysis in mature
adipocytes (47). Though there is little evidence regarding prostaglandins and insulin
resistance, one study did find that COX-2 inhibition in muscle cells exacerbates palmitate
induced inflammation and insulin resistance, possibly through inhibition of AKT
phosphorylation (48).
1.2.4

COX-2, Prostaglandins, and Inflammation.
Acute and chronic inflammation are complex processes that are very well studied,

but not always well-understood. A key enzyme in the regulation of inflammation is
cyclooxygenase (COX), specifically the inducible isoform, COX-2. COX-1 is
constitutively expressed in most cell types, but COX-2 is upregulated after an
inflammatory stimulus. The inducible isoform is responsible for the production of large
quantities of prostaglandin H2, which is quickly converted to other prostaglandins (PGs)
like PGE2, PGF2ɑ, and PGD2. These PGs have contradictory roles in inflammation. In
particular, PGE2, has been accurately described as “a proinflammatory factor with
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immunosuppressive activity” (49). PGE2 production is under the control of COX-2 and is
regulated by the enzyme’s cellular production and activity.
PGE2 is a potent and essential component of the innate and acquired immune
system, responsible for both driving local acute inflammation and initiating
immunosuppression and the resolution of inflammation. During acute inflammation,
arachidonic acid (AA), liberated from cellular membranes by phospholipase enzymes, is
metabolized to the precursor lipid mediator PGH2 by COX-1 and -2. It is important to
note that the immune system is complex and most tissues and cell types are capable of
producing chemokines and even PGs in response to inflammation or cellular damage.
While circulating monocytes and resident macrophage cells are generally among the first
innate immune cells to respond to local inflammation, they are soon followed by the
infiltration of other immune cells, like mast cells, T cells and dendritic cells (DC). PGE2
levels can have profound effects on their function. PGE2 promotes the attraction and
degranulation of mast cells, while also disrupting DC differentiation and suppressing the
production of the Th1 cytokine IFN-γ without interfering with the production of IL-4.
High concentrations of PGE2 supports a shift from a Th1 to a Th2 immune response that
is characterized by the secretion of less destructive cytokines, suppresses the activity of
natural killer cells, and inhibits the proliferation and activation of CD8+ cytotoxic T cells
by suppressing IL-2 and IL-2R production and signaling. PGE2 inhibits the activation and
enlargement of B-cells through a cyclic AMP (cAMP) mediated mechanism (50) while in
monocytes and dendritic cells, PGE2 inhibits the production and secretion of
chemoattractant molecules and suppresses the production of IL-12 and TNFα while
inducing macrophage IL-10 production and a regulatory phenotype via protein kinase A
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(PKA) (47, 51-55). The overall effect of increased endogenous production of PGE2 is that
of a shift towards an immunosuppressive environment that can promote the development
of chronic inflammation.
With regard to induction of inflammation, the role of COX-2 and prostaglandins
is well established. Prostaglandin production is upregulated early in the acute
inflammation process and PGE2 in particular initiates a spectrum of inflammatory
responses; PGE2 drives vasodilation, contributing to swelling and pain at the site of
injury, directly induces the production of IL-17 from Th17 cells, IL-23 from dendritic
cells, and promotes the expression of IL-23R by naïve CD4+ T cells (51). Non-steroidal
anti-inflammatory drugs (NSAIDS) are non-selective COX inhibitors that act to reduce
fever and pain by directly inhibiting enzyme activity and the conversion of AA to lipid
mediators and are commonly used to treat symptoms of chronic inflammation, like joint
pain in osteoarthritis. Conversely, COX-2 inhibition has been associated with increased
and prolonged inflammatory activity, due in part to the loss of PGE2. PGE2’s antiinflammatory role is less well understood, but studies have repeatedly shown that COX-2
inhibition in the late stages of inflammation slows resolution and inhibits tissue recovery
and repair. It has been suggested that the disparate actions of PGE2 might be
concentration dependent; low PGE2 favors an inflammatory phenotype while high
concentrations induce pro-resolution mechanisms. PGE2 mainly exerts its pro-resolution
effects through the suppression of cytokine and cytokine receptor production. In vitro
data using isolated CD11c+ dendritic cells revealed that administration of exogenous
PGE2 prior to lipopolysaccharide treatment inhibits TNFα production in a time and dose
dependent manner. This effect was replicated in vivo using mice; PGE2 administration
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into the peritoneal cavity prior to inoculation with LPS resulted in a drastic reduction of
TNFα production by CD11c+ dendritic cells, suggesting PGE2 may inhibit dendritic cell
activation, thereby reducing T cell migration and activation in localized inflammation
(56). Furthermore, several studies have demonstrated a role for the COX-2/PGE2 axis in
the polarization of macrophages towards an M2, antiflammatory phenotype. Inhibition of
COX-2 has been shown to enhance the polarization of macrophages towards the
inflammatory M1 phenotype, delaying the resolution of inflammation, an effect attributed
to the loss of PGE2 signaling (57-59).
This evidence of immunomodulation becomes important in the context of
atherosclerosis where use of selective COX-2 inhibitors (COXIBs) and NSAIDS has
been shown to significantly increase the risk of myocardial infarction. It is likely that a
shift towards a Th1 type immune response that favors the production of pro-atherogenic
cytokines, remodeling of the atheromatous plaque, and a decrease in plaque stability. It
has been suggested that while prostaglandin inhibition at the site of inflammation would
be beneficial, COX inhibition is systemic thereby subjecting immune cells to
immunomodulation by reduced prostaglandin production. This slow shift in immune
response may be the reason why myocardial infarction occurs weeks after the initiation of
NSAID therapy (60). Furthermore, it is possible that the COX pathway may be involved
in macrophage cholesterol homeostasis as it has been shown that COX-2 inhibition in
differentiated THP-1 macrophages induced a significant increase in foam cell formation
through uptake of acetylated LDL cholesterol (61).
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1.2.5

Macrophage polarization.
While macrophage cells are not the only immune cells that infiltrate adipose

tissue, they are commonly seen in crown-like structures surrounding hypertrophied
adipocytes and are often polarized toward an inflammatory state (62). Macrophage cells
can exist in many different polarization states that are induced through different signaling
cascades that have profound effects on both gene and protein expression profiles.
Classically activated, proinflammatory macrophages (M1), are induced by activation of
the toll like receptor 4 (TLR4) and through contact with interferon gamma (IFN-γ), while
alternatively activated macrophages (M2), are generally induced through contact with
interleukins like IL-4, IL-13, and IL-10 (63). Though widely used, the M1 and M2
terminologies are not all-encompassing and fail to describe the range of activation states
that can be described as either favoring inflammation or pro-resolution. For instance,
while IL-4, IL-13, and IL-10 all induce what has been described as an anti-inflammatory,
or M2-like, phenotype, each interleukin initiates a different signaling cascade and
subsequently produces varying cell types that can drive inflammation in different
directions.
In general, the induction of M1 polarization is characterized by increased
production of inflammatory cytokines like TNF-ɑ and upregulation of inducible nitric
oxide synthase (NOS2) and COX-2, which have been shown to be coregulated (64).
PGE2 is highly upregulated during the onset of acute inflammation in vivo and in vitro,
however, when endogenous PGE2 levels rise to high concentrations, they act to suppress
the production of nitric oxide (NO) and TNF-ɑ, serving to control the inflammatory
process and reduce the risk of damage to the area of inflammation (49, 53). Much of the
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data regarding the feedback mechanisms of PGE2 on macrophage polarization and
NOS2/NO relies on isolated tumor associated macrophages or in vivo response, and are
therefore difficult to compare directly to in vitro conditions. However, there is evidence
that peptidoglycan (PGN) produced by gram positive bacteria induces NOS2 directly
through a PGE2 dependent mechanism in isolated peritoneal macrophages. COX-2
inhibition in these primary macrophages prevented the upregulation of NOS2 by PGN, an
effect that was restored through the addition of exogenous PGE2 (65). Furthermore, the
addition of exogenous PGE2 to J774A.1 macrophages in culture cannot elicit the
production of NO, but causes a concentration dependent increase in the presence of LPS
while the induction of NO by LPS can be reduced through inhibition of COX-2 (66).
There is some evidence that COX-2 inhibition can influence the polarization of
tumor associated macrophages from that of an anti-inflammatory phenotype that
promotes tumor growth towards a more inflammatory phenotype that does not favor
tumorogenesis. However, the inhibition of COX-2 alone was not enough to alter
phenotype of M2 (IL-4/IL-13) polarized macrophages towards an M1-like state (67). As
mentioned above, high PGE2 concentrations in the local microenvironment favor a shift
towards Th2 mediated immunity and the production of anti-inflammatory cytokines, like
IL-4, that drive macrophages towards an anti-inflammatory, tolerogenic phenotype.
1.3
1.3.1

Environmental Factors in Metabolic Syndrome
Mechanisms of OC exposure in the development of metabolic syndrome:
It is highly unlikely that lifestyle and dietary changes alone can account for the

dramatic rise of overweight and obesity worldwide. Interestingly, it has been noted that
even animal populations that live in close contact with humans in industrialized nations,
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ranging from domesticated pets to feral rats, have become prone to developing obesity.
Klimentidis et. al. (2010) estimated the likelihood of this trend occurring purely by
chance in animal populations at 1 in 12 million, indicating that an exogenous
environmental factor is likely contributing to this development (68). Recent research has
suggested a strong association between pesticide and other environmental contaminant
exposure and development of T2D (69-71). One of the major groups of pesticides
implicated in this research are the legacy OC insecticides such as DDT and chlordane;
these OC insecticides were used heavily during the 1950’s and ‘60’s, but have been
banned in the US since the early 1970’s, however, legacy OC insecticides and their
metabolites can still be found in serum samples and fatty substances, such as breast milk,
in human populations both within the United States and abroad (72). Additionally, the
compounds can still be found in the US food supply (73) with detectable levels of OC
pesticides found in a selection of produce, fish, and dairy products available in a Texas
supermarket (13) and in sediment dwelling oysters harvested in marshes in Georgia (74).
More recent studies have indicated that these chemicals continue to persist in water and
sediments and still contaminate the tissues of game fish (12, 75) Humans are likely to be
exposed to OC compounds through diet and environment, and those living in highly
agricultural regions are likely to receive greater exposures and have higher pesticide body
burdens.
Evidence of an association between POPs and T2D continues to accumulate.
Cross-sectional studies have shown a strong dose-response relationship between serum
concentrations of persistent organic pollutants (POPs), including OC insecticides, and the
prevalence of diabetes (69, 71, 76, 77). One such study found that pesticide applicators
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who were exposed to persistent OC insecticides, specifically the cyclodiene compounds
aldrin, chlordane and heptachlor (as indicated by self-reports), had greatly enhanced
odds, 51%, 63%, and 94%, respectively, of developing T2D (78). A similar study
evaluating the prevalence of self-reported diabetes and OC exposure found a significant
association between self-reported diabetes and serum levels of oxychlordane, transnonachlor, β-hexachlorocyclohexane, and the highest levels of DDE exposure. It was also
reported that serum glucose levels were higher in individuals exposed to trans-nonachlor
and β-hexachlorocyclohexane (79). In another set of cross sectional studies, serum
concentrations of p,p’-DDE were significantly associated with BMI while exposure to
oxychlordane and trans-nonachlor was significantly associated with insulin resistance in
non-diabetic adults (76, 80). In a cohort study the same group found that exposure to
POPs predicted metabolic abnormalities in a population free of diabetes. In a 20 year
study, the authors found that baseline exposure to p,p’-DDE predicted higher BMI,
higher triglycerides, insulin resistance, and lowered HDL cholesterol, while transnonachlor and oxychlordane significantly predicted high triglycerides (10). A recently
published study conducted by Lind et al (2013) used an environmental wide association
study which integrated environmental exposures with lifestyle factors to identify p,p’DDE and PCB209 as significantly associated with metabolic syndrome when analyzed in
the context of fatty acid intake. DDE was positively associated with metabolic syndrome
with odds ratios of 1.46, while PCB209 was shown to be negatively associated, having an
odds ratio of 0.53. In this study, trans-nonachlor was considered borderline significant
with an odds raio of 1.3 (9).
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Animal models have been used to study the association between OC exposure and
insulin resistance and T2D with similar results. Rats exposed to a high fat diet containing
POP contaminated crude salmon oil exhibited increased accumulation of abdominal,
insulin resistant adipose tissue, elevated cholesterol levels, as well as significant
dysregulation of lipid homeostasis. In the same study, rats fed a similar high fat diet
containing refined and filtered salmon oil did not exhibit severe hepatosteatosis and did
not gain as much weight as those fed a high fat diet containing POPs (81). In a similar
study, adult male C57BL/6J mice were fed a very high fat diet (VHF) or western diet
(WD) with or without the addition of farmed salmon fillet (VHF/S and WD/S). Another
group of mice was fed a VHF diet supplemented with salmon fillet containing lower
concentrations of POPs (VHF/S-pops). Both diets supplemented with salmon fillet (VHF/S
and WD/S) exhibited increased insulin resistance, increased adiposity, and impaired
glucose tolerance. Additionally, muscle tissue from these mice did not exhibit AKT
phosphorylation or glucose uptake upon stimulation by insulin (82). Supporting this
finding, in silico protein docking analysis of DDT and its metabolites found that p,p’DDE in particular had a high affinity for several proteins involved in the insulin signaling
pathway: p,p’-DDE exhibited the highest affinity for AKT-1 followed by
phosphodiesterase 10A, PI3K p110, PKCθ, and Ser/Thr-protein kinase
serum/glucocorticoid regulated kinase 1 (Sgk1), suggesting a possible mechanistic link
between OC exposure and insulin resistance.
Several in vitro studies have indicated a role for OC exposure and enhanced
adipogenesis and altered lipid metabolism in mature adipocytes. One study found that
exposure to DDE, oxychlordane, or dieldrin increased basal fatty acid uptake in mature
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3T3-l1 adipocytes, while DDE and oxychlordane were unable to enhance adipogenesis
during the differentiation of 3T3-L1 cells. However, DDE exposure significantly
increased release of leptin, adiponectin, and resistin from mature adipocytes (83). It has
also been reported that p,p’-DDT was able to enhance differentiation in 3T3-L1 and 3T3F44A2 adipocytes, but DDT was not able to overcome the inhibitory effect of TNFα on
adipocyte differentiation (84).
DDT exposure is capable of inducing a significant immunomodulatory effect in
exposed animals and humans, however the data are conflicting, reporting both
immunosuppressive and inflammatory responses; moreover the data are rather limited.
Prenatal exposure to OCs like DDE is associated with increased relative risk of asthma,
respiratory infections, and otitis media in children (85). DDT and DDE have been shown
to activate the caspase cascade and induce TNF-α, IL-6, and IL-1β in peripheral blood
mononuclear cells (PBMCs), but it was reported that, in the presence of LPS, DDT
induced significant reduction in TNF-α secretion and nitric oxide generation, while
another study reported apoptosis in PBMCs exposed to similar concentrations of p,p’DDE (86-88).
DDE has been shown in vitro to inhibit the expression of inducible nitric oxide
synthase (NOS2) in IFN-γ stimulated J774A.1 macrophages, compromising their ability
to limit intracellular growth of the pathogen Mycobacterium microti (89). Furthermore, a
recent study found that rats exposed to p,p’-DDT were protected from hepatocellular
injury following ip injection of LPS. Livers from exposed rats were protected from LPS
mediated increases in apoptosis, immune cell infiltration, and TNF-ɑ and NOS2 mRNA
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expression. Interestingly, the overall findings of this study indicated that p,p’-DDT
reduced hepatic inflammation at the cost of regulation of lipid metabolism (90).
While the mechanism of immunomodulation by DDE is open for debate, several
studies have reported a dose dependent decrease in prostaglandin production following
DDE exposure (91, 92) which may cause adverse inflammatory effects in a manner
similar to COX-2 inhibition. Furthermore, one isomer of DDT, o,p’-DDT has been shown
to markedly increase incidence of microalbuminuria in a murine model of lupus, while
exposure to p,p’-DDE in lupus patients was associated with significant alterations in the
subpopulations of T-lymphocytes, specifically a reduction in regulatory T cells (93, 94).
Studies evaluating the immunomodulatory capacity of another OC, trans-nonachlor, are
limited, though our lab has found an association between trans-nonachlor and
atherosclerosis (unpublished data), indicating a potential role in the inflammatory
processes of CVD
1.4

Objectives
The overall hypothesis of this dissertation is that altered adipogenesis and

immunomodulation of adipose microenviroment by DDE may contribute to an “obese
phenotype” that predisposes an individual to developing metabolic disease. The research
was carried out with three specific aims:
Obesity often precedes the onset of diseases of chronic inflammation, such as
insulin resistance, T2D, and CVD. Data suggest that, following periods of persistent
weight gain and the onset of obesity, local inflammation in the visceral adipose tissue is
at least partially responsible for the development of the systemic, chronic inflammation
caused by ectopic lipid deposition in peripheral tissues, contributing to insulin resistance
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and increasing the risk of development of more serious conditions like T2D and CVD
(95, 96).
Exposure to environmental chemicals, like OC insecticides or their metabolites,
has been linked to increased risk of metabolic syndrome, T2D, obesity, and CVD (9, 97,
98). The aim of this research was to investigate the ability of the OC insecticide
metabolite, p,p’-DDE, to perturb homeostasis in the adipose tissue, providing evidence of
a possible mechanism by which DDE may alter the metabolic and inflammatory
processes that contribute to the development of disease.
1.4.1

Specific Aim 1: Evaluate the ability of DDE to alter adipogenesis under
suboptimal conditions.
Previous data generated in our lab found that DDE could not induce a significant

increase in adipogenesis in 3T3-L1 cells (83). However, it is possible that high
concentrations of powerful glucocorticoids present in standard adipogenic media may
mask the effect of OCs on differentiation; therefore it was hypothesized that a suboptimal
differentiation cocktail may yield different results. 3T3-L1 cells were induced to
differentiate in a suboptimal cocktail in the presence of DDE. Terminal differentiation
was assessed through neutral lipid staining in mature adipocytes, triglyceride
accumulation, and gene expression analysis of markers of differentiation by RT-qPCR.
1.4.2

Specific Aim 2: Evaluate the ability of DDE to modulate immune response
in macrophage cells in vitro.
DDE has been described as immunomodulatory, having effects on numerous

immune cell types. Of particular interest to this study is the finding that DDE can
interfere with the activity of COX-2, an enzyme responsible for the conversion of
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arachidonic acid to the prostaglandin, PGH2. Prostaglandins are lipid mediators that have
both pro- and anti-inflammatory activities in all cell types. The ability of DDE to inhibit
the production of prostaglandins following immune stimulus was evaluated in vitro using
murine J774A.1 monocytic macrophage cells and THP-1 cells, a human monocytic
leukemia cell line. The ability of DDE to alter macrophage polarization was also
assessed. J774A.1 cells were exposed to DDE, then induced to differentiate to M1 or M2
macrophages. Expression of specific genes for M1 and M2 phenotype, NOS2 and Arg-1,
respectively, were analyzed by RT-qPCR.
1.4.3

Specific Aim 3: Investigate the ability of DDE to alter the immune cell
populations of the adipose tissue stromal vascular fraction in vivo.
Recent research has shown that immune cell populations in the stromal vascular

fraction are significantly altered in the condition of obesity (26). DDE accumulates in
fatty tissue and it was hypothesized that acute exposure to the OC insecticide may alter
the immune profile of the adipose tissue. Male C57Bl mice were administered DDE by
oral gavage for 5 days, followed by sacrifice 12 hours after the final dose. The immune
cell populations of the epididymal adipose tissue were assessed through multi-color flow
cytometry. Macrophage (F4/80+CD11b+) cells from experimental and vehicle mice were
sorted for gene expression analysis by RT-qPCR to determine if DDE influenced the
polarization state of the macrophage population in exposed mice
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CHAPTER II
EXPOSURE TO P,P’-DDE ENHANCES DIFFERENTIATION AND ALTERS GENE
EXPRESSION IN 3T3 ADIPOCYTES IN A SUBOPTIMAL MODEL OF
DIFFERENTIATION

2.1

Introduction
The incidence of obesity and overweight has increased dramatically since the

1980’s and is contributing to a major health crisis worldwide. Obesity and overweight are
major risk factors for cardiovascular diseases, insulin resistance, type 2 diabetes, and
even some cancers (1, 2). Abdominal or visceral fat accumulation is the consequence of
excess nutrition in a state of physical inactivity and, relative to normal weight, is
significantly associated with all-cause mortality, especially when BMI >35. More than
two thirds (68.5%) of all adults in the United States are considered overweight or obese,
defined as having a body mass index (BMI) >25 and >30, respectively, with more than
one third (34.9%) of the population being obese (3).
Adipose tissue has long been recognized as the storage depot for triglycerides
derived from excess nutritional energy. This dietary energy is stored as triglyceride in
lipid droplets inside white adipocytes in many different white adipose tissue (WAT)
depots. While these depots were once thought to be inert, adipose is now recognized as a
regulatory tissue that helps maintain lipid and glucose homeostasis (4). WAT is not
homogeneous and contains many cell types, including mature adipocytes, immune cells,
33

pluripotent mesenchymal stem cells, and mesenchymal stem cells that have committed to
the preadipocyte lineage (5). Obesity results from adipocyte hyperplasia and hypertrophy
which leads to recruitment of immune cells to adipose tissue and eventually contributes
to localized chronic low-grade inflammation and adipocyte dysfunction (6, 7). In the
early stages of weight gain, excess energy is stored as lipid in mature adipocytes that
expand in size. Afterward, there is a rapid increase in the number of fat cells as
preadipocyte fibroblasts undergo proliferation and differentiation, a process called
adipogenesis, to increase the number of mature fat cells (8). A degree of local
inflammation occurs during this initial expansion phase and it has been suggested that
this inflammation may be a normal, healthy response that assists in the vascularization of
the growing tissue (9). However, in the setting of persistent over nutrition and the onset
of obesity, the adipose tissue loses its ability to expand and produce new adipocytes (4,
8). The continued hypertrophy of existing adipocytes eventually impairs ability of these
mature adipocytes to store lipids properly, resulting in ectopic fat storage in peripheral
tissues like muscle and liver (4).
Recent research has suggested a strong association between pesticide and other
environmental contaminant exposure and development of T2D (10-12). One of the major
groups of pesticides implicated in this research are the legacy OC insecticides such as
DDT and chlordane; these OC insecticides were used heavily during the 1950’s and
‘60’s, but have been banned in the US since the early 1970’s, however, legacy OC
insecticides and their metabolites can still be found in serum samples and fatty
substances, such as breast milk, in human populations both within the United States and
abroad (13). Additionally, the compounds can still be found in the US food supply (14)
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with detectable levels of OC pesticides found in edible sport fish from San Francisco
Bay, in sediment dwelling oysters harvested in marshes in Georgia, and in fruits and
vegetables (15, 16). A number of cross sectional epidemiological studies have linked
exposure to DDE with type 2 diabetes (T2D) and obesity. Recent human cohort studies
have established an increased relative risk of developing T2D in individuals with the
highest exposure levels (17, 18). Additionally, recent in vivo exposure studies in rodents
indicate that a high fat diet supplemented with persistent organic pollutants, including
DDE, resulted in increased visceral adiposity and increased macrophage infiltration when
compared to high fat diet alone (19, 20).
Several in vitro studies have indicated a role for OC exposure and enhanced
adipogenesis and altered lipid metabolism in mature adipocytes. It has been reported that
p,p’-DDT was able to enhance differentiation in 3T3-L1 or 3T3-F44A2 adipocytes (21).
Previous data from our lab found that exposure to p,p’-DDE (DDE), trans-nonachlor
(TNC), or dieldrin increased basal fatty acid uptake in mature 3T3-L1 adipocytes, while
DDE exposure significantly increased release of leptin, adiponectin, and resistin from
mature adipocytes. DDE and TNC were unable to enhance adipogenesis during the
differentiation of 3T3-L1 cells. (22). As the previous study used a potent cocktail to
induce complete differentiation (approximately 95%), in this study, a suboptimal
differentiation cocktail (approximately 45%) was used to assess the ability of DDE to
induce differentiation of 3T3 adipocytes.
2.2

Materials
3T3-L1 preadipocytes were purchased from American Type Culture Collection

(ATCC). Donor Calf Serum (BCS), penicillin/streptomycin were purchased from
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Hyclone. Fetal bovine serum (FBS), methylisobutylxanthine (IBMX), dexamethasone,
dimethyl sulfoxide (DMSO), and insulin were purchased from Sigma-Aldrich (St. Louis,
MO). Dulbecco’s modified Eagle’s medium (DMEM) was purchased from Fisher
Scientific. Triglyceride and MTT were quantified using kits from Cayman Chemical and
Bradford reagent was from Bio-Rad Co. Maxima First Strand cDNA synthesis kit and
Luminaris HiGreen Low ROX qPCR Master Mix were from Thermo Scientific
(Pittsburg, PA). p,p’-DDE was purchased from ChemService (West Chester, PA).
2.3
2.3.1

Methods
3T3-L1 Cell Culture
Murine 3T3-L1 fibroblasts (ATCC® CL-173; lot# 59239597) were purchased

from American Type Culture Collection. Upon receipt, 3T3-L1 vial was thawed in a
37°C water bath with gentle shaking. Cells were diluted in 9ml warm DMEM with 10%
calf serum and antibiotics, centrifuged at 300xg for 5 minutes at RT. Cells were
resuspended in growth media and seeded in a 25cm2 tissue culture flask. Cells were
cultured in growth media (GM) composed of DMEM with 10% calf serum and
antibiotics in a humidified incubator at 37°C with 5% CO2 atmosphere in tissue-culture
treated flasks. Maintenance media was exchanged every 2 to 3 days. Cells were
subcultured before reaching approximately 70% confluence. For subculture, media was
aspirated and cells were detached in 0.25% trypsin-EDTA. Cells were resuspended in
fresh media and subcultured at a ratio of 1:4. Low passage number cells were processed
for cryopreservation. Cells were detached in the described manner, centrifuged at 300xg
for 5 minutes at 4°C, then resuspended in growth media containing 5% sterile DMSO.
Cells were aliquoted into labelled Nunc Cryotubes, placed in a cryopreservation vessel at
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-80°C for at least 4 hours. Cells were transferred to -150°C for long term storage. 3T3
cells require contact inhibition to undergo adipogenesis, but cells lose adipogenic
potential if they are maintained at high density for extended periods of time.
Additionally, adipogenic potential is reduced with increasing passage number. As such,
any subcultures reaching greater than 80% confluence or cultured beyond passage 8 were
discarded.
2.3.2

Differentiation in Sub-optimal media
3T3 cells were detached as described above and seeded onto multi-well tissue

culture plates. Cells were grown to confluence in GM. Two days post confluence,
differentiation was initiated as previously described (Fig. 2.1) (23). Stock solutions of
p,p’-DDE were prepared in ethanol. Stock solutions of IBMX (500mM) were prepared in
DMSO, and dexamethasone was prepared as stock solution of 20 µg/ml in DMEM. The
differentiation media was composed of 500µM IBMX, 0.1µM dexamethasone, and
167nM human insulin followed by 0.1µM dexamethasone and 40nM human insulin in
DMEM containing 10% FBS and 100IU penicillin and 100µg/ml streptomycin, for day 0
and day 2, respectively. On day 4, media was exchanged for maintenance media
(DMEM containing 10% FBS) and refreshed every 48 hours. Vehicle (0.05% ethanol)
and increasing concentrations of DDE in ethanol (0.56µM, 1.0µM, 3.0µM, 5.6µM,
10µM, 18µM, 30µM, 56µM, 100µM) were added on day 0 and maintained in culture
until day 4. Full differentiation (MIX) was achieved by incubating confluent 3T3-L1 cells
with 500µM IBMX, 1µM dexamethasone, and 10 µg/ml human insulin followed by
10µg/ml human insulin alone in DMEM containing 10% FBS and 100IU penicillin and
100 µg/ml streptomycin, for day 0 and day 2, respectively. On day 4, media was
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exchanged for maintenance media (DMEM containing 10% FBS) and refreshed every 48
hours until day 8.

Figure 2.1

2.3.3

Dosing scheme for 3T3 suboptimal differentiation

Cell viability
The effect of DDE on cell viability was determined by 3-(4,5-dimethylthiazolyl-

2)-2, 5-diphenyltetrazolium bromide (MTT) based assay (24) (Cayman Chemical). 3T3
fibroblasts were seeded in 96-well plates and grown to confluence. After reaching
confluence, 3T3 cells were incubated in increasing concentrations of DDE (0.78µM100µM) for 24 hours. 10µl MTT reagent was added to each well and incubated for an
additional 4 hours at 37°C. Media was gently aspirated and remaining formazan crystals
were dissolved in the provided solvent. Absorbance was measured at 590nm according to
manufacturer’s directions.
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2.3.4

Assessment of lipid accumulation in 3T3 cells differentiated in sub-optimal
media.
Eight days after the initiation of differentiation, adipogenesis was assessed using

an Oil Red O (ORO) assay to measure intracellular lipid content as previously described
(22). ORO staining solution was prepared by dissolving 400mg ORO in 100ml
isopropanol overnight with stirring, filtered with .22µm filter, diluted 6:4 in ddH2O, then
filtered through a .22µm filter, and incubated at RT for 20 minutes. Prior to staining, cells
were washed with PBS, fixed in 10% formalin for one hour. Formalin was removed, and
cells were washed with 60% isopropanol and allowed to dry. Cells were stained for 10
minutes using Oil Red O working solution. Stain was removed and cells were washed 4x
with distilled H2O. Cells were allowed to air dry. Dye was extracted with 100%
isopropanol for 10 minutes with gentle rocking and measured spectrophotometrically at
520nm in a 96-well plate. In additional experiments, 3T3 cells were differentiated in the
described manner in the presence of vehicle, 10 and 20µM DDE. In the triglyceride
experiment only, rosiglitazone (500nM) was substituted for MIX cocktail to induce full
differentiation. Eight days after the initiation of differentiation, triglyceride (TG)
(Cayman Chemical) and protein content (Bradford; Bio-rad) were determined via
commercially available reagents according to manufacturer’s directions. Briefly, cells
were scraped in triglyceride assay diluent (provided), sonicated on ice, centrifuged at
10,000 x g for 10 minutes at 4°C, and the resulting supernatant was transferred to a clean
1.5ml centrifuge tube and stored at -80°C until analysis. Protein and TG content of the
supernatant was determined spectrophotometrically in 96 well plates, according to
manufacturer’s directions. TG content was normalized to protein content and expressed
as mg TG/mg protein.
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2.3.5

Adipogenic Gene Expression Analysis
Eight days after the initiation of differentiation, total RNA was extracted using

Qiagen RNeasy Mini plus kit according to manufacturer’s directions. RNA extracts were
frozen at -80°C until such time that cDNA was generated using a Maxima first strand
cDNA synthesis kit (Thermo Scientific) according to manufacturer’s directions. cDNA
was stored at -80°C. Expression of fatty acid binding protein 4 (FABP4), peroxisome
proliferator activated receptor-γ (PPARγ), fatty acid synthase (FASn), sterol regulatory
element-binding protein 1c (SREBP1c), glucose transporter type 4 (Glut4), and leptin
(LEP) were analyzed in 3T3-L1 cells. β-actin (ACTB) was chosen as the reference gene
for terminal differentiation (25). Primer sequences are listed in Table 2.1.Two-step
quantitative real-time polymerase chain reaction (RT-qPCR) was performed on a
Stratagene MXP3005 using Taqman-based Luminaris Higreen low ROX qRT-PCR
reagents. Fold change in gene expression was estimated using the ΔΔCt method and
statistical significance was determined as previously described (26, 27).
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Table 2.1

Primer Sequences for Terminal Differentiation

Gene Name

Gene Symbol

Primer Sequence (5'-3')

β Actin

Actb

F: GTCGAGTCGCGTCCACC
R: GTCATCCATGGCGAACTGGT

peroxisome proliferator activated receptor-γ

Pparg

F: GAAAGACAACGGACAAATCACC
R: GGGGGTGATATGTTTGAACTTG

Sterol Regulatory Element-Binding Protein 1c

Srebf1

F: AAGCTGTCGGGGTAGCGTC
R: GAGCTGGAGCATGTCTTCAA

Leptin

Lep

F: CAGGATCAATGACATTTCACACA
R: GCTGGTGAGGACCTGTTGAT

Fatty acid binding protein 4

Fabp4

F: TGAAAGAAGTGGGAGTGGGC
R: CCAGCTTGTCACCATCTCGT

Faciliated glucose transporter member 4

Slc2a4

F: GACGGACACTCCATCTGTTG
R: GCCACGATGGAGACATAGC

Fatty acid synthase

Fasn

F: AGATGGAAGGCTGGGCTCTA
R: GAAGCGTCTCGGGATCTCTG

2.3.6

Statistical Analysis.
Data are expressed as mean with +/- standard error (SE). Statistical significance

was determined by one-way ANOVA with Duncan’s Studentized range test for multiple
comparisons using PROC GLM in SAS 9.3 (SAS Institute, Cary, NC).
2.4

Results and Discussion
Figure 2.2 shows lipid accumulation (red staining) in 3T3 cells differentiated in a

suboptimal cocktail in the presence of vehicle (A), 20µM DDE (B), compared with fully
differentiated adipocytes (C). Cells differentiated in the presence of DDE exhibited
significantly increased differentiation in a concentration dependent manner, with a
maximal effect at 56µM (Fig 2.3). Oil Red O staining is not quantitative, so intracellular
lipid content was measured using a commercial triglyceride assay. DDE treatment
significantly increased triglyceride accumulation at both the 10 and 20µM concentrations
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by 42% and 58%, respectively, compared with ethanol control. Triglyceride
accumulation was significantly different between the two DDE treatment groups, with the
higher concentration inducing enhanced triglyceride accumulation. None of the
concentrations used in this study were able to induce full differentiation as compared
with 500nM rosiglitazone in suboptimal differentiation cocktail or compared with the
standard, full potency differentiation cocktail (Fig. 2.3 and 2.4). The influence of DDE on
3T3 cell viability was assessed via serial dilution and measured by the MTT viability
assay. With the exception of the highest concentration (100µM), the concentrations of
DDE used did not reduce viability of 3T3 adipocytes as determined by MTT assay (Fig.
2.5). This was not entirely unexpected as the cells differentiated in the presence of
100µM DDE exhibited distinct morphological differences, visible under inverted
microscope, and were susceptible to detachment of the monolayer from the tissue culture
plate during differentiation.

Figure 2.2

Oil Red O staining of differentiated adipocytes

Representative photomicrograph of adipocytes differentiated using suboptimal cocktail in
the presence of vehicle (A), 20µM DDE (B) compared with fully differentiated
adipocytes (C).
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Figure 2.3

Effect of increasing concentrations of DDE on 3T3 adipogenesis.

Differentiating 3T3 cells were exposed to increasing concentrations of DDE in a suboptimal differentiation cocktail for the first four days of differentiation. Full
differentiation (MIX; 95% differentiation) was achieved using 1mM dexamethasone,
500mM IBMX, and 10 µg/mL human insulin. Eight days after the initiation of
differentiation, cells were stained with Oil Red O and dye was extracted and measured
spectrophometrically at 520nm. Data (n=4-7) are expressed as mean fold change
compared to vehicle +/- standard error (SE). Statistical significance was determined by
one-way ANOVA with Duncan’s Studentized range test for multiple comparisons using
PROC GLM in SAS 9.3 (SAS Institute, Cary, NC). Means with different letters indicate
significant difference at P<0.05.
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Figure 2.4

Effect of DDE on triglyceride accumulation.

Data (n=5) are expressed as mean triglyceride (mg TG/mg protein) +/- standard error
(SE). Differentiating 3T3 cells were exposed to vehicle (0.05% ethanol), 10 or 20µM
DDE in a sub-optimal differentiation cocktail for the first four days of differentiation.
Full differentiation was achieved through the addition of 500nM rosiglitazone for the first
4 days of differentiation (500nM ROSI). Eight days after the initiation of differentiation,
triglyceride content was extracted and measured using commercial reagents (Cayman
Chemical). Statistical significance was determined by one-way ANOVA with Duncan’s
Studentized range test for multiple comparisons using PROC GLM in SAS 9.3 (SAS
Institute, Cary, NC). Means with different letters indicate significant difference at
P<0.05.

44

Figure 2.5

Effect of DDE on 3T3 viability.

Confluent 3T3-L1 cells were exposed to vehicle, increasing concentrations of DDE for
24 hours. Viability after 24 hours was determined by MTT assay (Cayman Chemical)
Data (n=3) are expressed as percent of control +/- standard error (SE). Asterisks indicate
significant differences from vehicle control P<0.05.
The finding that DDE could increase 3T3 differentiation under suboptimal
conditions was supported by changes in expression of several lipogenic genes (Fig. 2.6).
The data are presented as fold change over undifferentiated control. Comparison to
suboptimal vehicle control can be found as supplementary data in section A.1.
DDE exposure enhanced the expression two of genes that facilitate differentiation,
SREBP1c and FAS. SREBP1c is a transcription factor found in adipose tissue that
induces the expression of several genes involved in glucose and lipid metabolism and
homeostasis, such as fatty acid synthase. DDE treatment increased the expression of the
transcription factor SREBP1c at all treatment concentrations compared to sup-optimal
vehicle control, however only the 10µM concentration was significantly different, as
determined by one-way ANOVA, Fig (2.6A). Furthermore, expression of fatty acid
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synthase (FAS), a lipogenic enzyme that facilitates adipogenesis, was significantly
enhanced at the 2.5 and 20µM concentrations (Fig 2.6 B). Fatty acid binding protein 4
(FABP4), a membrane associated protein that is thought to be involved in the uptake,
transport, and metabolism of long chain fatty acids, was increased significantly by all
concentrations of DDE (Fig 2.6 F).
The expression of markers of differentiation (that are not expressed by preadipocyte cells) was enhanced in all treatments receiving the suboptimal differentiation
cocktail, indicating that the 3T3 cells differentiated in the suboptimal cocktail did
undergo differentiation. Expression of leptin (Lep) was enhanced across all DDE
concentrations, and was significantly increased compared to sub-optimal vehicle control
(Fig 2.6 D). This supports the findings that DDE may be influencing differentiation
through the enhancement of lipid uptake and storage since increased leptin signaling is
associated with an increase in lipid accumulation. Secretion of leptin was not assessed in
this study, but previous data reported in this cell line indicates that DDE exposure does
enhance leptin secretion (22).
Expression of Glut4, a glucose transporter, was increased in all treatments
compared to undifferentiated cells (Fig 2.6 E), however, there were no significant
differences between any of the treatments grown in the suboptimal cocktail vs. MIX
cocktail (Fig 2.6D). Additionally, expression of PPAR-γ, a transcription factor that is
induced in early differentiation and regulates the transcriptional activation of genes
responsible for adipogenesis and lipid metabolism, including FABP4 (28), was enhanced
across all treatments compared to undifferentiated cells. The finding that expression of
these markers of differentiation, Glut4 and PPAR-γ, was not significantly different
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between suboptimal vehicle and MIX differentiated cells indicates these genes were
already maximally expressed, so it is not surprising that DDE did not significantly
increase their expression.
These data support the finding that DDE can enhance adipogenesis and lipid
accumulation in differentiating 3T3 adipocytes. It should be noted that the standard error
for all genes and treatments were very large. This is likely due to the small sample size
(n=3) and could be minimized through analysis of additional samples, but further analysis
is beyond the scope and timeframe of this study.
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Figure 2.6

Effect of DDE on gene expression

Data (n=3) are expressed as mean fold change compared to undifferentiated cells +/standard error (SE). Differentiating 3T3 cells were exposed to increasing concentrations
of DDE (2.5, 10, and 20µM) or Vehicle (V; 0.05% ethanol) in a sub-optimal
differentiation cocktail for the first four days of differentiation. Full differentiation
(MIX; 95% differentiation) was achieved using 1µM dexamethasone, 500mM IBMX,
and 10 µg/mL human insulin Eight days after the initiation of differentiation, cDNA was
synthesized from total RNA and quantified by RT-qPCR. Statistical significance was
determined by one-way ANOVA. Means with different symbols indicate significant
difference at P<0.05
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2.5

Conclusions
Some of the data found in this research were novel and provide evidence of

DDE’s ability to influence adipogenesis and the expression of adipogenic genes,
however, it is important to recognize some of the limitations of this study. The findings
herein were limited to an in vitro model utilizing concentrations representative of
individuals falling within the 95th percentile exposure range, as reported by the 20032004 NHANES study (22). Furthermore DDT and its metabolites are not readily soluble
in media and are most often dissolved in organic solvents to improve solubility. Previous
data generated by our lab used DMSO as a vehicle to facilitate dissolution of
hydrophobic DDE in culture media (22). However, it has been reported that when DMSO
is used to deliver DDT to mature adipocytes, those cells take up 5-fold more compound
than when DDT was contained within chylomicrons, and DDT uptake occurred at a
significantly faster rate (29). Ethanol was chosen as the vehicle for this study, however,
similar data evaluating the use of ethanol as a solvent for DDT or DDE were not readily
available, and such a study was beyond the scope of this research. Furthermore, while a
low concentration of ethanol was used for this study (0.05%), ethanol has been shown to
perturb lipid metabolism in the whole animal. However, preliminary data using Oil Red
O staining indicated that 3T3 cells differentiated under suboptimal conditions were not
significantly different from cells differentiated without ethanol (Table 2.2)
Table 2.2

No effect of ethanol on 3T3 differentiation under suboptimal conditions

Treatment
Control
0.05% Ethanol

Mean Abs. (±SE)
1.024
1.065
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p<0.05
n.s.

Previous in vitro studies investigating the effect of DDE on adipogenesis have
been conducted under conditions that induce near complete adipogenesis using potent
glucocorticoids. Since such potent conditions could mask any potential effect of DDE on
differentiation, cells were differentiated under suboptimal conditions in the present study.
In conclusion, the present findings of this study provide evidence that DDE at high
concentrations may be able to enhance differentiation. DDE induced significant increases
in the expression of several genes related to adipogenesis and lipid metabolism. While
exposure to OC compounds like DDE has been associated with increased risk of
metabolic disease and T2D (18, 30), there is no evidence of a direct causal relationship
between exposure and development of disease. These data suggest that DDE may
enhance both adipogenesis and lipid uptake and storage through altered gene expression,
resulting in more adipocytes capable of accumulating lipid. This may predispose an
individual with high exposure to developing increased visceral adiposity in the setting of
prolonged excess dietary intake.
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CHAPTER III
P,P’-DDE INHIBITS THE CONVERSION OF ARACHIDONIC ACID TO
BIOACTIVE PROSTAGLANDINS AND ALTERS MACROPHAGE
ACTIVATION IN J774A.1 CELLS.

3.1

Introduction
Exposure to environmental chemicals has been associated with perturbations of

normal metabolic homeostasis, implicating them as possible contributors to the global
obesity epidemic. One class of compounds, organochlorine (OC) pesticides, is associated
with increased risk of metabolic syndrome (MS) and type 2 diabetes (T2D). Most OC
compounds are very lipophilic and bioaccumulate in mammals, sequestering mainly in
fatty tissues like adipose. There have been numerous epidemiological studies that have
shown not only an association between serum concentrations of persistent organic
pollutants (POPs) and T2D and MS (1, 2), but also an increased risk of development of
these conditions in people initially free of disease (3).
The exact etiology of metabolic syndrome has not been determined, but weight
gain and obesity are associated with a chronic, low-grade inflammatory state that has
been linked to the development of T2D and cardiovascular disease (CVD) (4). While the
intimate relationship between metabolism and immunity is not fully understood and
cannot be accurately defined using classical models of inflammation (5), inflammation is
commonly accepted as one of the key contributors to metabolic disease in obese and
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overweight individuals. Furthermore, adipose tissue in obese individuals (obese adipose
tissue) is now recognized as a major source of circulating inflammatory cytokines and
adipokines that contribute to chronic, low-amplitude systemic inflammation commonly
seen in metabolic diseases (6, 7). Adipose tissue expansion during weight gain is an
inflammatory process that elicits the infiltration of immune cells, like macrophages (810). It has been suggested that, while it may seem counterintuitive, an acute inflammatory
response during high-fat feeding and weight gain may be necessary for healthy fat
storage and that a loss of acute inflammation may predispose an individual to developing
chronic inflammation, like that seen in metabolic syndrome and insulin resistance (11).
Chronically inflamed adipose tissue is a significant source of inflammatory
cytokines like TNF-α, MCP-1, and IL-6, produced mainly by resident immune cells, as
well as the adipokines resistin and leptin, which are secreted by adipocytes. These
compounds are capable of causing systemic inflammation and exacerbating insulin
resistance in the peripheral tissues. Some OC compounds have been shown to be
immunomodulatory, capable of both enhancing and suppressing the immune system, and
as such, may be able to contribute to the altered inflammatory state observed in metabolic
syndrome. In particular, one metabolite of the banned pesticide DDT, p,p’-DDE, has
been associated with increased risk of metabolic syndrome and type 2 diabetes in cross
sectional studies (12-14). Furthermore, a 20-year prospective study found that exposure
to DDE and other OCs has been shown to predict diagnosis of disease later in life in
individuals that were initially free of disease (3). In vivo data seem to support this
finding, as rats exposed to a high fat diet contaminated with a mixture of POPs, including
DDE, developed signs of the metabolic syndrome, including elevated cholesterol,
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hepatosteatosis, and perturbed lipid homeostasis (15). Similar results were obtained when
this same lab group exposed C57Bl/6J mice to western-style diets containing salmon oil
contaminated with POPs. These mice exhibited increased macrophage infiltration into the
adipose tissue and transcripts of the inflammatory cytokines TNF-ɑ, NOS2, and IL-6
were elevated in fat tissue samples (16).
Several studies indicate that DDE may have immunomodulatory properties that
might allow it to contribute to the perturbed inflammation seen in diseases like MS and
T2D, the data are, however, limited and often conflicting. Prenatal exposure to OCs like
DDE is associated with increased relative risk of asthma, respiratory infections, and otitis
media in children (17). DDT and DDE have been shown to increase the production of
TNFα, IL-6, IL-1β as well as activate the caspase cascade in peripheral blood
mononuclear cells (PCMBs). However, these same authors also report that DDE was able
induce apoptosis of PCMBs at very similar concentrations to those that induced cytokine
production (18-21). DDE has been shown in vitro to inhibit the expression of inducible
nitric oxide synthase (NOS2) following IFN-γ stimulation of J774A.1 macrophages,
compromising their ability to limit intracellular growth of the pathogen Mycobacterium
microti (22). Furthermore, a recent study found that rats exposed to p,p’-DDT were
protected from hepatocellular injury following ip injection of LPS. Livers from exposed
rats were protected from LPS mediated increases in apoptosis, immune cell infiltration,
and TNF-ɑ and NOS2 mRNA expression (23).
Several studies have found DDT and its metabolites are capable of interfering
with the activity and expression of the enzyme cyclooxygenase (COX), specifically the
inducible isoform, COX-2. COX-2 is responsible for the metabolism of arachidonic acid
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to prostaglandin H2, which is then metabolized to one of many prostaglandins (PGs) like
PGE2, PGF2ɑ, and PGD2. These PGs, particularly PGE2, are highly involved in the
regulation of inflammation and can either exacerbate or help alleviate inflammation.
These PGs are also involved in the activation of macrophage cells, like those in the
adipose tissue, and can drive their polarization state towards an inflammatory or antiinflammatory profile.
As MS and T2D are diseases of inflammation, this provides a possible mechanism
in which DDE exposure may contribute to increased risk of disease in the setting of
obesity. While the mechanism of immunomodulation by DDE is open for debate, several
studies have reported a concentration dependent decrease in prostaglandin production
following DDE exposure which may cause adverse inflammatory effects in a manner
similar to COX-2 inhibition (24, 25). In this study, we investigated DDE’s ability to
inhibit the production of PGE2 and to alter the polarization status of macrophage cells.
3.2
3.2.1

Materials and Methods
Materials.
Murine macrophage cell line J774A.1 (ATCC® TIB-67™; lot# 603780631) were

purchased from American Type Culture Collection. Certified fetal bovine serum (FBS)
was purchased from Life Technologies. DMEM was purchased from Corning. Molecular
biology grade ethanol, sodium palmitate, and E. coli lipopolysaccharide (LPS) were
purchased from Sigma-Aldrich. DDE was purchased from Chem Service, Inc.
Arachidonic acid and N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulfonamide (NS398) were purchased from Cayman Chemical. Fatty acid free, low endotoxin bovine
serum albumin (BSA) was from Gemini biologicals. Maxima First Strand cDNA
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synthesis kit and Luminaris Color HiGreen low ROX RTq-PCR kits were purchased from
Thermo Scientific. Murine recombinant interleukin-4 (IL-4) and interferon gamma (IFNγ) were purchased from BioLegend (San Diego, CA).
3.2.2

J774A.1 macrophage cell culture
Murine macrophage cell line J774A.1 (ATCC® TIB-67™; lot# 603780631) was

purchased from American Type Culture Collection. Upon receipt, J774A.1 vial was
thawed in a 37°C water bath with gentle shaking. Cells were diluted in 9ml warm DMEM
with 10% FBS and 100IU penicillin and 100µg/ml streptomycin, centrifuged at 300xg for
5 minutes at RT. Cells were resuspended in growth media and seeded in a 25cm2 tissue
culture flask. Cells were cultured in growth media (GM) composed of DMEM with 10%
FBS and 100IU penicillin and 100µg/ml streptomycin in a humidified incubator at 37°C
with 5% CO2 atmosphere in tissue-culture treated flasks. Media was exchanged every 2
to 3 days. Cells were subcultured before reaching approximately 70% confluence. For
subculture, media was aspirated and 5-10ml fresh GM was added each flask and cells
gently scraped with a rubber policeman. Cells were resuspended in fresh media and
subcultured at a ratio of 1:4. Low passage number cells were processed for
cryopreservation. Cells were detached in the described manner, centrifuged at 300xg for
5 minutes at 4°C, then resuspended in growth media containing 5% sterile DMSO. Cells
were aliquoted into labelled Nunc Cryotubes, placed in a cryopreservation vessel at 80°C for at least 4 hours. Cells were transferred to -150°C for long term storage. Cells
were never passaged beyond 20 passages.
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3.2.3

Assessment of cell viability
The effect of DDE on cell viability as determined by 3-(4,5-dimethylthiazolyl-2)-

2, 5-diphenyltetrazolium bromide (MTT) based assay (26) (Cayman Chemical). J774A.1
macrophages were seeded in 96-well plates and grown to 80% confluence. Cells were
incubated with 2.5, 10, or 20µM DDE, 10µM NS-398, 0.05% ethanol (vehicle), 0.005%
Triton-X100, or left unstimulated. Cells were incubated for 2, 6, 12, and 18 hours. MTT
reagent (10µl) was added to each well for the last 4 hours of incubation, with the
exception of the 2 hour time point, when MTT reagent was added at the same time as the
chemicals. Media was gently aspirated and remaining formazan crystals were dissolved
in the provided solvent. Absorbance was measured at 590nm according to manufacturer’s
directions.
3.2.4

Conjugation of free fatty acid to BSA
Palmitic acid was conjugated to BSA in the following manner: All equipment was

soaked overnight in a 1% solution E-Toxa-Clean®, rinsed 5 times with hot tap water, 5
times with DI water and twice with endotoxin-free water and air-dried in a tissue culture
hood, then autoclaved. Under sterile conditions, 2.5g BSA and 25ml sterile PBS was
added to a 50ml glass beaker to make a 10% BSA solution. The solution mixed with
gentle stirring and filter sterilized using a .22µm filter. 3.5mg sodium palmitate and
200µl molecular biology grade ethanol were added to a separate sterile beaker containing
a small stir bar and gently swirled. 8.5ml sterile BSA solution was added to the sodium
palmitate and the solution was stirred with gentle heating under aseptic conditions until
the solution was clear (about 20 minutes). Sterile 10% BSA and conjugated palmitic
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acid-BSA (PA-BSA; final concentration: 1.5mM) solution were aliquoted into small,
sterile glass vials using sterile borosilicate glass pipettes and stored at -20°C until use.
3.2.5

Prostaglandin production
J774a.1 cells at 80% confluence were incubated 2 hours in serum-free DMEM

containing vehicle (0.05% EtOH), 10µM NS-398, 2.5, 10, or 20µM DDE, followed by
the addition of 250 ng/ml LPS, 0.5% BSA, or 100µM PA-BSA for an additional 4 hours.
Following stimulation, supernatant was removed and centrifuged to pellet cell debris.
Supernatant was mixed 1:2 in ethyl acetate containing 0.1% acetic acid and 3µl 2.5mM
[2H4)-8-iso-PGF2ɑ. Samples were vortexed and centrifuged at 500 x g for 3 minutes at
RT. Organic layer was transferred to a clean tube and dried under a gentle stream of
nitrogen, resuspended in 1:1 water/methanol, and transferred to glass vial with insert for
UPLC- ESI-MS/MS analysis.
3.2.6

Effect of DDE on prostaglandin production in a cell free system
J774a.1 macrophages were seeded in 75cm flasks and grown to 80% confluence.

Cells were washed once with PBS and given DMEM with 1 µg/ml LPS and incubated for
4 hours. Cells were scraped in 1ml Hanks Balanced Salt Solution and sonicated on ice.
50µl cell lysate was added to a clean glass tube containing 2.5, 5, 10, or 20µM DDE,
0.05% ethanol, or 10µM NS-398 in Tris-HCl to a final volume of 1ml. Cell lysates were
incubated for 15 minutes in a water bath at 37°C , followed by the addition of 10 µM AA.
Samples were vortexed vigorously and incubated for an additional 30 minutes at 37°C
then centrifuged for 10 minutes at 10000 x g at 4°C to pellet cellular debris. The resulting
supernatants were stored at -80°C until analysis by UPLC ESI-MS/MS.
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3.2.7

Prostaglandin extraction and detection by UPLC ESI-MS/MS
Arachidonic acid and prostacyclin levels in cell culture supernatant or from cell-

free supernatants were measured by UPLC- ESI-MS/MS. Briefly, internal standards were
added to supernatant and media was extracted using ethyl acetate and with 0.1% acetic
acid. Samples were mixed, centrifuged, and the resulting organic layer removed and dried
under nitrogen. Samples were resuspended in 1:1 water:methanol and transferred to a
glass vial with conical insert for analysis. PGE2 and PGF2ɑ were quantified using a
Waters Acquity Ultra Performance Liquid Chromatograph coupled to a Thermo
Scientific TSQ Quantum Access MAX triple quadrupole mass spectrometer (27).
Chromatography was performed on a BEH C18 2.1x50mm column with water/methanol +
0.1% acetic acid as the mobile phase. UPLC/ESI-MS/MS analysis of PGE2 and PGF2α by
single reaction monitoring (SRM) was accomplished by monitoring the transitions m/z
351271 and m/z 353193, respectively. The internal standard [2H4]-8-iso-PGF2α was
monitored by the transition m/z 357197.
3.2.8

Macrophage Polarization.
J774a.1 cells were seeded in 12 well plates and grown to 80% confluence. Cells

were incubated for 2 hours in media containing vehicle (0.05% ethanol), 2.5 or 10µM
DDE, or 10µM NS-398, then incubated for an additional 24 hours with either LPS (100
ng/ml) and IFN-γ (20 ng/ml) or IL-4 (20 ng/ml) in the presence of each treatment
compound. Following stimulation, cells were washed with sterile PBS. Cell monolayer
was lysed in 350µl Buffer RLT Plus containing 10 µl/ml β-mercaptoethanol, vortexed,
and homogenized using Qiagen Qiashredders according to manufacturer’s directions.
Total RNA was extracted using Qiagen RNeasy Plus mini extraction kit according to
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manufacturer’s direction and cDNA was generated using Maxima First Strand cDNA
synthesis kit (Thermo Scientific). Expression levels of inducible nitric oxide synthase
(NOS2) and arginase 1 (Arg-1) were analyzed as markers of M1 and M2 macrophage
polarization, respectively. Two-step quantitative real-time polymerase chain reaction
(RT-qPCR) was performed on a Stratagene MXP3005 using Taqman-based Luminaris
Higreen low ROX qRT-PCR reagents. Expression levels were measured using primers
purchased from Life Technologies and normalized to β-actin and expressed as foldchange with respect to control. Fold change in gene expression was estimated using the
ΔΔCt method and statistical significance was determined as previously described (28,
29). Primer sequences were as follows: NOS2 sense, TGGGTCTTGTTCACTCCACG;
NOS2 antisense, GGAACATTCTGTGCTGTCCC; arginase sense,
TTTTAGGGTTACGGCCGGTG; arginase antisense, CCTCGAGGCTGTCCTTTTGA;
COX-2 sense, GGGCCATGGAGTGGACTTAAA; COX-2 antisense,
ACTCTGTTGTGCTCCCGAAG; β-actin sense, GTCGAGTCGCGTCCACC; β-actin
antisense GTCATCCATGGCGAACTGGT.
3.2.9

Statistical methods
Statistical significance was determined by Student’s t-test or one-way ANOVA

with Duncan’s Studentized range test for multiple comparisons using PROC GLM in
SAS 9.3 (SAS Institute, Cary, NC).
3.3

Results
Preliminary data using human monocytic leukemia cell line THP-1 and murine

macrophage-like cell line RAW264.7 (ATCC) indicated DDE inhibited PGE2, PGD2, and
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PGF2ɑ secretion following inflammatory stimulus (See appendix A.2 for data summary).
In RAW and THP-1 macrophages, this effect could be partially reversed through the
addition of the cAMP generating compound, 3-isobutyl-1-methylxanthine (IBMX).

It

was suspected that this effect of DDE was COX-2 dependent; COX-2 preferentially
produces PGE2, which induces its own production as well as the expression of NOS2,
potentiating inflammation in a cAMP dependent manner.
Despite obtaining preliminary data in alternative cell lines, J774A macrophagelike cells were chosen for this study. RAW264.7 macrophage cells do not express all of
the PGE2-specific receptors (EP1-4), specifically lacking EP1, and produce high basal
levels of PGE2. PGE2’s actions on its receptors are concentration dependent and
contradictory. THP-1 monocytic cells must be induced to differentiate through the use of
phorbol methyl esters, and it has been reported that the resulting phenotype can be greatly
influenced by the concentration of differentiation factors. Furthermore, it has been
suggested that the COX-2 mediated production of PGE2 and the subsequent modulation
of NO production is more physiologically relevant in J774A.1 cells vs. RAW264.7 (30).
None of the treatment concentrations used in this study were determined to be
directly cytotoxic to J774A.1 cells as determined by MTT assay (Fig 3.1).
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Figure 3.1

18 hour MTT viability assay

J774A.1 macrophages were seeded in 96-well plates and grown to 80% confluence. Cells
were left unstimulated or incubated with 0.05% ethanol (vehicle) 2.5, 10, or 20µM DDE,
10µM NS-398. Viability was assessed using MTT reagent. Data are expressed as percent
change from unstimulated control. Statistically significant differences were determined
with one-way ANOVA with Duncan’s Studentized range test for multiple comparisons.
Treatment groups (n=3/group) were not significantly different from unstimulated control
or each other P <0.05.
3.3.1

DDE inhibits prostaglandin production from cells stimulated with LPS
J774A.1 macrophages stimulated with DDE and given 250 ng/ml LPS produced

significantly less PGE2 than vehicle control while PGF2ɑ was only detectable in the
vehicle samples stimulated with LPS (Fig 3.2). Contrary to preliminary data obtained
using THP-1 and RAW264 macrophage cells, PGs were not detectable in the media of
cells stimulated with PA-BSA. This could possibly be due to greater overall production
of PG by these two cell types. Alternatively, a more rigorous protocol to control LPS
contamination was utilized to produce conjugated sodium palmitate for this study, since it
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is possible that the PG production seen in the preliminary data was due to low levels of
LPS contamination in the PA-BSA solution.

Figure 3.2

PGE production from LPS stimulated J774A.1 macrophage cells

J774A.1 macrophages were incubated with indicated treatment for 2hrs in serum free
media, then given a stimulus of 250 ng/ml LPS for an additional 4hr. Cell culture
supernatant was collected, prostaglandin production was measured by UPLC-ESIMS/MS, and total area ratios were estimated for each sample. Data are expressed as fold
change from vehicle (0.05% EtOH). Statistically significant differences were determined
with one-way ANOVA with Duncan’s Studentized range test for multiple comparisons.
Treatment groups (n=3/group) with the same letter are not significantly different at
ɑ=0.05.
3.3.2

DDE inhibits the metabolism of arachidonic acid to lipid mediator
metabolites in a cell free system
DDE inhibited the conversion of exogenous arachidonic acid to PGH2 (and the

subsequent conversion to PGE2 and PGF2ɑ) in a cell free system as determined by UPLCESI-MS/MS analysis. DDE caused a concentration-dependent decrease in the production
of PGE2 (Fig 3.3, Top), while PGF2ɑ production was significantly reduced at all
concentrations, with the exception of 2.5µM, which was not significantly different from
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ethanol vehicle (Fig 3.3, Bottom). The fold reduction in PGE2 and PGF2ɑ compared to
ethanol vehicle was not as robust as the inhibition seen in intact J774A.1 cells stimulated
with 250 ng/ml LPS. As with the intact cell assay, the fold reduction in PGF2ɑ by all
concentrations of DDE was more pronounced than that of PGE2. Maximal inhibition of
PGE2 generation was approximately 55%, of vehicle control, achieved by 20µM DDE
and 10µM NS-398, while PGF2ɑ production was reduced by as much as 65% by NS-398.
DDE (5, 10, and 20µM) inhibited PGF2ɑ by approximately 60%.
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Figure 3.3

Inhibition of Prostaglandin Production in a Cell Free System

J774A.1 cells were incubated with 1µg/ml LPS for 6 hours, scraped in HBSS and lysed
by sonication. 50µl cell free lysate was added to 1ml Tris-HCl containing vehicle
(EtOH), 2.5, 5, 10, or 20µM DDE, or 10µM NS-398 and incubated at 37°C for 15
minutes. Samples were spiked with arachidonic acid (10µM) and incubated for an
additional 30 minutes at 37°C. Prostaglandin production was measured by UPLC-ESIMS/MS and total area ratios were estimated for each sample. Data are expressed as fold
change from vehicle. Statistically significant differences were determined with one-way
ANOVA with Duncan’s Studentized range test for multiple comparisons. Treatment
groups (n=3/group) with the same letter are not significantly different at ɑ=0.05.
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3.3.3

Arg-1 and NOS2 mRNA expression reflect the activation stimulus of
J774A.1 macrophages
The polarization state of M1 vs M2 murine macrophage in vitro is reflected in

mRNA expression of NOS2 and Arg-1, respectively. This has been established in both
primary macrophage cultures and RAW264.7 macrophage (31, 32). RAW264.7 are often
used for polarization studies, but were not suitable for this particular investigation due to
aberrations in basal PGE2 secretion and autocrine PGE2 signaling. To ensure that NOS2
and Arg-1 expression accurately reflected polarization stimulus, J774A.1 macrophage
cells polarized to M1 or M2 macrophage phenotype using 20 ng/ml IFN-γ and 100ng/ml
LPS or 20 ng/ml IL-4, respectively. It was found that IFN-γ and LPS co-stimulation
significantly upregulated NOS2 and COX-2 mRNA while significantly down regulating
Arg-1 expression. IL-4 significantly upregulated Arg-1 mRNA expression, but had no
effect on the expression of NOS2 or COX-2 (Fig 3.4). It was determined that stimulus
had no significant effect on expression of internal control gene, β-actin (P<0.05) (28).
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Figure 3.4

24 hour M1/M2 macrophage polarization markers in J774A.1 macrophages

J774A.1 macrophage cells were grown to 80% confluence and induced to differentiate to
M1 or M2 macrophage phenotype using 20 ng/ml IFN-γ and 100ng/ml LPS or 20 ng/ml
IL-4, respectively. 24 hours later, total RNA was isolated and analyzed for M1 (NOS2)
and M2 (Arg-1) polarization markers and COX-2 expression by RT-qPCR. Statistically
significant differences between stimulus and control were determined with Student’s ttest P<0.05 vs No Stim.
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3.3.4

DDE alters the expression of M1 polarization markers in J774A.1 cells
stimulated with IFN-γ and LPS
In agreement with previously reported data, DDE and NS-398 inhibited the

expression of NOS2 (22, 30, 33). The most pronounced inhibition of NOS2 was
potentiated by the selective COX-2 inhibitor, and while 10µM DDE also induced
significant reduction in NOS2 mRNA expression, the inhibition was less pronounced.
The reduction of COX-2 mRNA by DDE after 24 hours is in agreement with data
reported in epithelial cells (24). Somewhat surprising was the drastic reduction in Arg-1
expression by NS-398 and 10µM DDE, each inducing approximately 1600 fold reduction
over unstimulated control, an approximately 4.5 fold decrease compared to stimulated
vehicle control (Fig 3.5).
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Figure 3.5

Fold Change in M1 polarization markers in J774A.1 cells

J774A.1 macrophage cells were grown to 80% confluence and induced to differentiate to
M1 macrophage phenotype using 20 ng/ml IFN-γ and 100 ng/ml LPS in the presence of
vehicle (0.05% EtOH)), 10µM NS-398, 2.5 or 10µM DDE. 24 hours later, total RNA was
isolated and analyzed for M1 (NOS2) and M2 (Arg-1) polarization markers and COX-2
expression by RT-qPCR. Comparisons were made between stimulated cells and
unstimulated control. Statistically significant differences were determined with one-way
ANOVA with Duncan’s Studentized range test for multiple comparisons. Treatment
groups (n=3/group) with the same letter are not significantly different at ɑ=0.05
3.3.5

DDE enhances Arg-1 expression in J774A.1 macrophages stimulated with
IL-4
Previous data from RAW264.7 and bone marrow derived macrophage cells

indicate that COX-2 inhibition alone was not sufficient to impair the polarization of M2
macrophages in the presence of IL-4 (31). Our data were in agreement with the finding
COX-2 inhibition alone is unable to reverse M2 polarization, however, unlike the
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reported data, selective COX-2 inhibitor NS-398 and DDE (2.5 and 10µM) significantly
increased Arg-1 expression over vehicle stimulated with IL-4. All treatment groups
significantly inhibited NOS2 mRNA expression in the presence of IL-4 when compared
to unstimulated vehicle control. IL-4 stimulation did not induce any significant changes
to COX-2 expression in any of the treatment groups when compared to unstimulated
vehicle control (Fig 3.6).

Figure 3.6

Fold Change in mRNA expression in J774A.1 cells stimulated with IL-4

J774A.1 macrophage cells were grown to 80% confluence and induced to differentiate to
M2 macrophage phenotype using 20 ng/ml IL-4 in the presence of vehicle (0.05%
EtOH)), 10µM NS-398, 2.5 or 10µM DDE. 24 hours later, total RNA was isolated and
analyzed for M1 (NOS2) and M2 (Arg-1) polarization markers and COX-2 expression by
RT-qPCR. Comparisons were made between stimulated cells and unstimulated control.
Statistically significant differences were determined with one-way ANOVA with
Duncan’s Studentized range test for multiple comparisons. Treatment groups (n=3/group)
with the same letter are not significantly different at ɑ=0.05
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3.4

Discussion
Though widely used, the M1 and M2 terminologies are not all-encompassing and

fail to describe the range of activation states that can be described as either favoring
inflammation or pro-resolution. For the sake of this study, however, we define as M1
polarization as IFN-γ + LPS activated macrophages while M2 refers to IL-4 activation.
Our data indicate that J774A.1 cells polarized towards the M1 phenotype in the presence
of a selective COX-2 inhibitor and the highest concentration of DDE had reduced
transcription levels of NOS2 and COX-2. These two enzymes have been shown to be coregulated and, interestingly, NO has been demonstrated to inhibit COX-2 activity through
nitration of Tyr385 (34). It is possible that, in our experiments, the reduced expression of
NOS2 in NS-398 and 10µM DDE exposed cells exposed to IFN-γ and LPS did not result
in a significant reduction in the production of NO. Arg-1 and NOS2 compete for the same
substrate, L-arginine, to produce ornithine and NO, respectively. The significant
reduction of Arg-1 mRNA (>4 fold reduction vs stimulated vehicle) by NS-398 and
10µM DDE may have resulted in the preferential production of NO, despite the decrease
in NOS2 mRNA expression. While data from the cell free assay indicates direct
interference with the COX-2 enzyme by DDE, the fold change in inhibition of PGE2 and
PGF2ɑ from intact cells was more pronounced following stimulation with LPS.
Quantification of NO production in differentiating M1 (IFN-γ + LPS) cells could provide
some insight as to whether there is a synergistic effect occurring through the direct
inhibition of COX-2 by DDE and NS-398 and the preferential metabolism of L-arginine
to NO mediated by a decrease in Arg-1 transcription.
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Future studies to elucidate the involvement of DDE in the alteration of
macrophage polarization should involve the addition of exogenous PGE2 to the media of
cells differentiating in the presence of IFN-γ and LPS. Measurement of NOS2, Arg-1,
and COX-2 mRNA as well as quantification of intracellular NO production could
strengthen the hypothesis that DDE influences alterations in immune activation in a
COX-2/PGE2 mediated manner.
Referring to activated macrophages as either M1 or M2 is a vast
oversimplification of the true multitude of phenotypes exhibited by macrophages. While
expression of Arg-1 and NOS2 are considered to be hallmarks of overall murine M2 and
M1 polarization, respectively, these two genes are not at all sufficient to completely
characterize the phenotype of each polarization state (35). Analysis of cytokine
production patterns (TNF-ɑ, IL-6, IL-10), phosphorylation status of STAT6 (M2) or
STAT1 (M1), as well as identification of surface antigen expression for M2 (CD206) and
M1 (CD80, MHC-I) by immunohistochemistry or flow cytometry would aid in the
determination the relative activation state of macrophages exposed to DDE. Metabolic
syndrome and T2D are very much diseases of metabolic and inflammatory dysfunction
and are suspected to be, in part, driven by perturbed macrophage activity in obese adipose
tissue (6, 36). Inflammation, particularly the chronic, low-grade metabolic inflammation
present in obesity and insulin resistance, is complex and not always well understood.
Inflammation and the resolution thereof requires feedback mechanisms between both
immune cells and local tissues involving cytokine and lipid mediator pathways to
properly eliminate an immune insult without causing overt damage to the self. The data
presented suggest that DDE can inhibit the release of prostaglandins, particularly PGE2
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and PGF2ɑ in a COX-2 dependent mechanism in J774A.1 cells. Furthermore, DDE
altered gene expression in differentiated macrophages in the same manner as a specific
COX-2 inhibitor administered in equimolar concentrations. The results of this study
suggest that DDE may influence the activation and activity of macrophages during an
inflammatory challenge in vivo, a possibility supported by recently published data
indicating that the parent compound, p,p’-DDT, can alter hepatic inflammation following
LPS stimulus (23). Any compound that can influence the activity or function of the
immune system could contribute to dysfunction both locally and systemically. By altering
PG synthesis and macrophage polarization, DDE may contribute to immune system
dysfunction, such as that seen in metabolic syndrome or insulin resistance.
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CHAPTER IV
THE EFFECT OF P,P’-DDE ON THE STROMAL VASCULAR FRACTION OF
MALE C57BL/6J MICE

4.1

Introduction
Obesity is a disease of epidemic proportions that is linked to the pathogenesis of

metabolic syndrome, cardiovascular disease (CVD), and type 2 diabetes mellitus (T2D)
and represents a lifelong health threat to affected individuals. Increasing adiposity is
associated with a chronic, low-grade inflammatory state that has been linked to the
development of T2D and CVD and may be due, in part, to the infiltration of immune cells
into the visceral adipose tissue (1).
The intimate relationship between metabolism and immunity is not fully
understood and cannot be accurately defined using classical models of inflammation (2).
However, inflammation is commonly accepted as one of the key contributors to
metabolic disease in obese and overweight individuals. Furthermore, adipose tissue in
obese individuals (obese adipose tissue) is now recognized as a major source of
circulating inflammatory cytokines and adipokines that contribute to chronic, lowamplitude systemic inflammation commonly seen in metabolic diseases (3, 4). Adipose
expansion and proliferation occurs rapidly in response to excess dietary intake, requiring
angiogenesis to support the growing tissue (5, 6). The exact progression of disease is still
subject to debate, but it is thought that, during weight gain, adipose tissue hypertrophy
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and expansion induces tissue remodeling, involving the microvasculature and
extracellular matrix, causing changes in the stromal vascular compartment, which is
comprised of pluripotent mesenchymal stem cells, preadipocyte fibroblasts, endothelial
cells, and immune cells (5, 7). Leukocyte infiltration into the adipose tissue occurs
rapidly in response to high-fat feeding, though the exact mechanism of immune cell
recruitment is subject to debate (1). It has been suggested that the microvasculature of the
visceral adipose may be more readily induced to express adhesion molecules that would
recruit migration of leukocytes into the adipose tissue (8). It is also possible that
expansion of the immune cell population occurs through local proliferation within the
tissue itself (9).
As innate immune cells infiltrate into adipose tissue, the adipokine and cytokine
secretory profile shifts towards an inflammatory state. The infiltration of macrophages
and immune cells into the adipose tissue and the subsequent production of
proinflammatory cytokines by both macrophages and adipocytes likely alter adipose
tissue function, leading to systemic insulin resistance. Inflammation of the adipose tissue
does not mimic acute inflammatory processes that resolve quickly; rather, it is
characterized by a long-duration and low-amplitude inflammatory response (9). Chronic
inflammation of adipose tissue impairs proper triglyceride storage and the excess lipids
are transported to peripheral tissues and deposited in liver and muscle tissues. Ectopic
triglyceride deposition in muscle and liver disrupts cellular function by interfering with
mitochondrial β-oxidation and by inducing stress signaling pathways that inhibit insulin
stimulated glucose uptake, thereby contributing to the development of insulin resistance
(10, 11).
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As adiposity increases and macrophage infiltration progresses, a feedback loop
involving saturated fatty acids and cytokines, including TNFα, is established between
hypertrophic adipocytes and immune cells that drives a vicious cycle of inflammatory
changes; secretion of TNFα, IL-6, MCP-1, and leptin is increased while antiinflammatory compounds like adiponectin and IL-10 are downregulated (10). The
population of other innate immune cells in the stromal vascular fraction (SVF) also
undergoes changes as well. One study found CD11c+ dendritic cells are increased during
the early stages of diet induced obesity (DIO) and comprise a large proportion of the
F4/80+ cells of myeloid origin. These cells were found in the crown-like structures that
surround hypertrophied adipocytes in obese adipose tissue and caused the recruitment of
other CD11b+ and F4/80+ macrophages (12). High-fat feeding studies have found
increased numbers of cytotoxic CD8+ T cells, CD31+ endothelial cells, and CD11b+
F4/80+ cells after 16 weeks of high fat diet, while CD4+ T helper cells and
CD4+CD25+Foxp3+ Tregs are significantly reduced (11). Additionally, it has been shown
that T-cells from obese diabetic and obese non-diabetic people exhibit inflammatory
profiles (13). These studies suggest that adipose tissue inflammation is a complex process
involving adipose tissue remodeling that can be initiated and propagated though changes
in immune cell populations.
4.2

DDT and Metabolic Syndrome
The current increase in prevalence of T2D has been commonly attributed to a

western-style diet combined with a sedentary lifestyle, but there is a growing body of
evidence suggesting that exogenous chemicals, particularly endocrine disrupting
chemicals (EDCs), may contribute to the development of obesity and metabolic
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syndrome (14). One class of chemicals often implicated in this association is persistent
organic pollutants (POPs). Exposures to high concentrations of chlorinated compounds
and chlorinated pesticides, particularly polychlorinated biphenyls (PCB) and
organochlorine (OC) pesticides, have been consistently associated with increased odds of
disease status. In a longitudinal study, exposure to OC pesticides and PCBs predicted
increased risk of development of T2D and metabolic syndrome in people initially free of
disease (15). One pesticide in particular, p,p’-DDE, a metabolite of DDT, is significantly
associated with increased odds of T2D (15, 16), predicted higher body mass index (BMI),
triglycerides, insulin resistance, and is associated with metabolic syndrome (14). Though
this chemical has been banned for decades in most developed nations, it is still used in
many developing countries and has a long half-life. p,p’-DDE persists in the environment
for decades and bioaccumulates up the food chain, sequestering in fatty tissues (17).
Data suggest that exposure to p,p’-DDE, among other POPs, may lead to insulin
resistance and associated metabolic disorders. Ruzzin et. al. reported increased
abdominal obesity and insulin resistance in rats following consumption of a high fat diet
supplemented with crude salmon oil containing high levels of POPs, including p,p-’DDE
(18). Similarly, male C57BL/6J mice fed a very high fat or western style diet
supplemented with salmon filet (containing POPs) exhibited higher visceral adiposity
with more F4/80+ cells within crown-like structures surrounding adipocytes. These mice
also presented with insulin resistance and glucose intolerance (19). In vitro data show that
DDT and p,p’-DDE can induce pro-inflammatory effects, inducing cytokine production
and anti-oxidant responses in peripheral blood monocytes (20, 21), as well as
immunosuppressive properties by reducing resistance to infection (22). Data regarding
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the association between OC exposure and lymphocyte populations is conflicting, with
some reporting lower levels of CD4+ CD45+ lymphocytes, as well as decreased T-cell
proliferative responses in infants exposed prenatally (23) while others report no
association between p,p’-DDE exposure and percentages of lymphocyte subpopulations
(24).
Obesity is described as an inflammatory state, characterized by adipocyte
hypertrophy and macrophage infiltration and the establishment of a feedback loop that
perpetuates chronic, low-grade inflammation (25). Changes in adipose tissue immune cell
populations, from shifting ratios of lymphocytes to a shift in macrophage polarization,
have been described in obese and insulin resistant adipose tissue (2, 11) To date, there
has not been an investigation into the localized effect of p,p’-DDE on the immune cell
populations of the stromal vascular fraction (SVF) of visceral adipose tissue. As
lipophilic compounds such as p,p’-DDE are sequestered in the adipose and are found at
significantly higher concentrations than in the blood (17), it was hypothesized that this
pesticide may exert a local effect on macrophage population. Preliminary data (see
appendix A.3) suggested a shift in the F4/80+CD11b+ population, with more doubly
positive macrophage cells present in the adipose of mice exposed to DDE. Therefore,
further testing was conducted to validate the finding that DDE exposure caused an influx
of F4/80+CD11b+ macrophage cells into the epididymal adipose tissue. This population
of cells was isolated by FACS and subjected to PCR analysis to determine if the
macrophage populations between experimental and control mice exhibited a skewed M1
or M2 morphology.
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4.3

Materials
Collagenase type IV was purchased from Worthington (Lakewood, NJ). Hanks

balanced salt solution (HBSS), certified fetal bovine serum (FBS), and Dulbecco’s
phosphate buffered saline (DPBS) were purchased from Life Technologies. CD45-APC
(Clone: 30-F11) and F4/80-PE-Cy7 (Clone: BM8) antibodies were purchased from
Biolegend, CD11b-PE (Clone: M1/70) was purchased from Thermo Scientific. Fixable
viability stain eFluor 780 was purchased from eBioscience. Low-endotoxin, fatty acidfree bovine serum albumin (BSA) was purchased from Gemini Bioproducts. Fc Block
and Pharm Lyse were purchased from BD Bioscience. EDTA and DNase 1 were
purchased from Sigma. 100µm cell strainers and phenol red free RPMI were purchased
from Fisher Scientific. HEPES was purchased from MP Biomedicals.
4.3.1

Animals
Male C57BL/6J mice were obtained from Jackson Laboratories at 6 weeks of age.

All mice were housed under a 12-hour light-dark cycle and allowed free access to food
and water. The mice were housed in an AAALAC accredited facility under standard
conditions, and Institutional Animal Care and Use Committee (IACUC; protocol number
14-003) approved protocols were followed.
4.4

Methods
At eight weeks of age, mice were considered sexually mature and

immunologically stable. To examine p,p’-DDE induced changes on the stromal vascular
fraction, mice were administered corn oil vehicle or p,p’-DDE (2 mg/body weight, 1 mg/
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ml solution) by oral gavage once per day for 5 days. Animals were sacrificed by CO2
asphyxiation 12 hours after the final dose.
4.4.1

Serum Collection.
Following CO2 asphyxiation, animals were cleansed with 70% isopropanol, and

blood was withdrawn via cardiac puncture using 21G 5/8” needle connected to a 1ml
sterile syringe and transferred to a prepared 1.5ml centrifuge tube. Blood was allowed to
clot at room temperature for 30 minutes, then centrifuged for 10 minutes at 8000 x g at
4°C to collect serum. Serum was transferred to a new 1.5ml centrifuge tube and stored at
-80°C.
4.4.2

Dissection and tissue collection.
SVF fraction was isolated as previously described, with modifications(26). Full

isolation protocol and optimization can be found in appendix A.2. Collagenase type 4
solution (10 mg/ml) was prepared in digestion buffer (HBSS with Ca2+ and Mg2+ and
0.2% low-endotoxin, fatty acid-free BSA) the morning of sacrifice. Animals were placed
in a supine position and abdominal skin opened along the midsaginal line. Peritoneum
was carefully opened and epididymal fat pads were isolated, excised, weighed in a small
weigh boat, and finely minced in a 15ml tube containing 8ml sterile digestion buffer.
Tubes were kept on ice until all animals were processed. Collagenase type 4 was added to
each tube at a final concentration of 1 mg/ml and digestion buffer to 10ml. Tubes were
incubated in a 37°C water bath for 30 minutes with vigorous shaking and gentle inversion
at 5 minute intervals throughout the incubation. Following digestion, EDTA was added to
each tube to a final concentration of 10mM and samples were incubated for an additional
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5 minutes at 37°C. Samples were filtered through 100um nylon strainers into 50ml
conical bottom tubes containing 10ml RPMI with 2% heat inactivated FBS and 25mM
HEPES. Digestion tube and cell strainer were washed twice with 5ml RPMI. Cells were
centrifuged at 400xg for 7min at 4°C. Floating adipocytes and supernatant were removed
with gentle aspiration. 0.5ml 1X BD Pharm Lyse was added to each tube and samples
were gently vortexed and incubated for 5 minutes in the dark in order to lyse red blood
cells. Cells were resuspended in 10ml serum free RPMI and centrifuged at 400xg for 5
min at 4°C. Supernatant was decanted and cells were resuspended in 500µl serum and
protein free PBS for immunostaining.
4.4.3

Stromal Vascular Fraction Cell Count
Aliquots (20µl) were taken from each sample for cell counting. Aliquots were

mixed 1:1 in trypan blue, vortexed gently, and counted using a hemocytometer. Cell
number was normalized to total volume of cells in suspension (500-700µL)
4.4.4

Immunostaining and Flow Cytometry.
The total volume of cell suspension was strained through 35um filter into a 5ml

flow cytometry tube. Samples were washed with 3ml serum and protein free PBS by
centrifugation at 400xg for 5 min at 4°C. Supernatant was decanted and cells were
resuspended in a total volume of 1ml serum/protein free PBS. 1µl eFluor 780 fixable
viability stain was added to each tube and samples were incubated for 30 minutes at 4°C.
Cells were washed in FACS-PBS (Ca and Mg free DPBS containing 0.2% fatty acid free,
low-endotoxin BSA) at 400xg for 5 min at 4°C. Supernatant was decanted and cells were
incubated with Fc block (BD Biosciences) to reduce non-specific staining, followed by
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direct surface staining for 30 min at 4°C temperature in the dark using antibodies
purchased from Thermo Scientific or Biolegend. Macrophage/monocyte populations
were identified using CD45-APC (Biolegend; 30-F11), CD11b-PE (ThermoScientific;
M1/70), and F4/80-PE-Cy7 (Biolegend; BM8). Following surface labeling, cells were
washed once in FACS-PBS, then resuspended in 400µl FACS-PBS. Samples were
analyzed immediately following staining using a FACSAria flow cytometer (Beckton
Dickson). Analysis was conducted using FlowJo software (TreeStar, Ashland, OR).
Macrophage cell number was normalized to total fat pad weight.
4.4.5

Cell Sorting and RNA extraction.
In some experiments, following surface staining, samples were resuspended in

sterile, RNase free FACS-PBS containing DNase I. 20,000 CD11b+F4/80+ events were
sorted into 500uL Buffer RLT plus(27). Following sort, final volume was adjusted to
bring the total volume of RLT buffer to 350uL for every 100uL of FACS sample volume,
and 250uL of 100% ethanol was added for every 450uL of RLT/FACS mixture. RNA
was immediately extracted using Qiagen RNeasy Mini Plus extraction kit. cDNA was
generated using Maxima First Strand cDNA synthesis kit and expression of Arg-1,
CD206, TLR-4, and NOS2 were measured by two-step quantitative real-time polymerase
chain reaction (RT-qPCR), performed on a Stratagene MXP3005 using Taqman-based
Luminaris Higreen low ROX qRT-PCR reagents. Fold change in gene expression was
estimated using the ΔΔCt method and statistical significance was determined as
previously described (28, 29).
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Table 4.1

Macrophage primer sequences

Gene Name
β Actin

Gene Symbol
Actb

Arginase 1 (Arg-1)

Arg-1

CD206

CD206

Inducible nitric oxide synthase

NOS2

Toll-like receptor 4 (TLR4)

TLR4

4.4.6

Primer Sequence (5'-3')
F: GTCGAGTCGCGTCCACC
R: GTCATCCATGGCGAACTGGT
F: TTTTAGGGTTACGGCCGGTG
R: CCTCGAGGCTGTCCTTTTGA
F: TTGCACTTTGAGGGAAGCG
R: CCTTGCCTGATGCCAGGTTA
F: TGGGTCTTGTTCACTCCACG
R: GGAACATTCTGTGCTGTCCC
F: TGGTTGCAGAAAATGCCAGG
R:
AGGAACTACCTCTATGCAGGG

Statistical Analysis.
Statistical significance was determined by one- or two-tailed Student’s t-test or

one-way ANOVA using PROC GLM in SAS 9.3 (SAS Institute, Cary, NC).
4.5

Results
FACS analysis of the SVF of mice exposed to DDE revealed a significant

increase (p<0.05) in the number of CD11b+F4/80+ in the epididymal adipose tissue by
approximately 38%. Interestingly, mice exposed to DDE for 5 days gained an average of
2.6 grams compared to 0.9 grams gained by corn oil vehicle, but this increase was not
significant at the p=0.05 level. There was no significant difference in total fat pad weights
between the groups. Furthermore, the total number of cells isolated from the SVF of DDE
exposed mice was increased by approximately 26%, but this was also not significant at
the p=0.05 level. Finally, CD11b+F4/80+ cells were sorted into RLT plus buffer for RNA
isolation. Gene expression analysis of known markers of macrophage polarization
revealed that there were no significant differences between the expression of Arg-1,
CD206, or TLR4, while NOS2 could not be detected in any of the samples.
89

Figure 4.1

Change in ATM cell population

Epididymal adipose tissue from mice exposed to 2mg/kg DDE or corn oil vehicle was
isolated, minced, subjected to collagenase digestion. The stromal vascular fraction from
the adipose tissue was collected and analyzed by multicolor flow cytometry. The
percentage of CD11b and F4/80 positive cells was quantified for each animal and
normalized to adipose tissue weight in grams. The adipose tissue from DDE exposed
animals contained approximately 38% more cells/g fat than control mice. This was
significant as determined by one-way student’s t-test (p<0.05).
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Figure 4.2

FACS gating strategy.

Representative example of macrophage population analysis by FACS. The CD45+
leukocyte population was first identified (top), and live cells were identified as cells that
did not stain positive for eFluor780 (middle). Finally, after doublet discrimination, cells
that were positive for CD11b and F4/80 were identified in Q2 (bottom).
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4.6

Discussion
There is a documented and rapid change in the composition of the adipose tissue

stromal vascular fraction in response to high fat feeding. Whether this initial change is an
early compensatory mechanism meant to orchestrate proper growth and maintain healthy
adipose tissue(30) or a response that is pathological in nature is subject to debate(3). The
data presented here indicate that DDE is capable of increasing the number of macrophage
cells/gram of adipose tissue in exposed mice, though it is unknown if this is the result of
recruitment from circulation or if the increased numbers are the product of resident
adipose tissue macrophage proliferation in response to DDE exposure. Furthermore, DDE
did not induce a change in the expression of macrophage polarization markers in cells
isolated from adipose tissue. This is not entirely unexpected, since in the absence of highfat feeding, there is little stimulus for polarization other than the DDE itself and
preliminary data (unpublished from our lab) indicate that DDE exposure alone has no
effect on the expression of either Arg-1 or NOS2 in resting murine macrophages. The
mice in the study were fed standard chow and were not given any inflammatory stimulus.
Data from ongoing in vitro studies in our lab indicate that DDE exposed macrophages
produce fewer prostaglandins, particularly PGE2 and PGF2ɑ, upon administration of an
inflammatory stimulus. The role of inflammatory lipid mediators, like prostaglandins, in
adipogenesis and adipose tissue inflammation in vivo are not well defined. However,
considering their contrasting actions in inflammation and the resolution thereof, any
changes in adipose tissue macrophage reactivity or number could result in an improper
inflammatory response and a failure to return to metabolic homeostasis in the setting of
high fat feeding(30).
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Furthermore, after 5 days of dosing, 2mg/kg DDE induced increases in the
number of stromal vascular cells and induced an average weight gain of 2.6 grams in
exposed mice, but neither of these increases were significant at p=0.05 level. This weight
gain is not surprising, given that our collaborators have found that mice administered the
same dose of DDE for 5 days and allowed to rest for an additional 7 days weighed
significantly more than corn oil control when both groups are fed a standard chow
diet(31).
4.7

Conclusion
To date, this is the first study to present evidence that environmental chemicals

can influence the composition of the stromal vascular compartment of adipose tissue. The
results of this study indicate that, even in the absence of dietary changes, DDE can
significantly enhance the migration of macrophage cells into the epididymal adipose
tissue of male C57 mice
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CHAPTER V
CONCLUSIONS AND FUTURE DIRECTIONS

There is a strong association between exposure to environmental contaminants
like DDE and prevalence of diseases like obesity, metabolic syndrome, and type 2
diabetes. While the pesticide DDT has been banned for decades in most countries, it is
still produced and used in a few locations and its metabolite DDE still persists in the
environment to this day. Because of its long half-life and its association with diagnosis of
disease, serum concentrations of DDE have been investigated as a potential biomarker to
help identify individuals at risk of developing disease.
The purpose of this body of research was to investigate potential mechanisms by
which DDE may influence the development of diseases like T2D and MS. Obesity often
precedes the development of metabolic syndrome, insulin resistance, and diseases like
T2D and cardiovascular disease (CVD). These diseases are, by and large, the product of
immune dysfunction though the etiology of that dysfunction is subject to debate.
However, there is a large body of evidence to suggest that the adipose tissue may play no
small part in loss of metabolic homeostasis seen in metabolic syndrome. Firstly, adipose
tissue expansion is an inflammatory process that requires adipocyte hypertrophy and
hyperplasia, the proliferation of pluripotent stem cells, and the growth of the
microvasculature within the tissue. The rapid growth of the adipose tissue has described
as similar to that of a tumor, which is not entirely inaccurate and can help illustrate the
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inflammation process that occurs within the expanding adipose, especially as it occurs in
adulthood.
In lean, healthy adipose tissue, most immune cells of monocytic lineage express
cell surface markers that identify them as belonging to an anti-inflammatory phenotype,
typically referred to collectively as M2. It has been shown that as adipose tissue expands
under the conditions of prolonged high fat feeding, the profile of immune cells in the
stromal vascular compartment, particularly the macrophage population, shift towards that
of an inflammatory profile, with macrophages largely representing those of the M1
phenotype. Recently, it has been argued that the inflammatory response seen in obesity is,
initially, a normal physiological response that helps coordinate the proper and healthy
expansion of the adipose tissue, allowing for proper storage of lipid within the growing
adipocytes and promoting the development of the extracellular matrix without the
development of fibrosis. The authors of that study then demonstrated that a loss of
inflammation within the adipose at the onset of high fat feeding resulted in impaired
glucose tolerance and peripheral lipid deposition, indicating that macrophage infiltration
and inflammation in the adipose tissue is not necessarily always deleterious. Regardless
of whether adipose tissue inflammation is initially pathological or physiological in nature,
if the inflammation is not resolved, the tissue cannot return to homeostasis and chronic
inflammation can occur as a result.
In this study, it was found that DDE can increase adipogenesis in 3T3-L1 cells
grown under suboptimal conditions. Should this effect also occur in vivo, it is possible
that individuals exposed to high levels of DDE may have more mature adipocytes within
their adipose tissue that are capable of accumulating lipid during high fat feeding,
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contributing to obesity. Because they are found in adipose tissue and would likely
encounter the chemical in high concentrations, macrophages were also exposed to DDE.
It was found that DDE could profoundly affect the ability of macrophage cells to produce
bioactive lipid mediators, known as prostaglandins, in a manner similar to that of specific
COX-2 inhibitor. Furthermore, DDE and a specific COX-2 inhibitor (NS-398) altered
gene expression in J774A.1 cells polarized towards an M1 (IFN-γ + LPS) or M2(IL-4)
activation state. NS-398 and the high concentration of DDE decreased expression of
NOS2, Arg-1, and COX-2 in cells stimulated with IFN-γ and LPS, while in IL-4
stimulated macrophages, NS-398 and both concentrations of DDE increased expression
of Arg-1. Lastly, DDE was shown to enhance macrophage accumulation in the adipose
tissue of male C57Bl mice exposed to the compound for 5 days.
It is possible that, while DDE may enhance adipogenesis, it had an equally
important role in immunomodulation. Arg-1 and NOS-2 compete for the same substrate,
L-arginine, to make ornithine and nitric oxide (NO), respectively. Arg-1 limits substrate
availability for NOS2, reducing its ability to produce NO thereby limiting cellular
damage and reducing local inflammation. These two genes are considered to be markers
of overall polarization, but they by no means fully characterize activation states.
However, the fact that DDE can affect the expression of these two genes may indicate
that the OC can interfere with the overall polarization state of a macrophage. A
macrophage’s activation state is determined by the cellular milieu in which is exists and
the signals it receives. In turn, differentially polarized macrophages can profoundly affect
their environment through their different secretory profiles of cytokines and
prostaglandins that can both drive inflammation and lead to resolution.
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In this context, the data presented here indicate that DDE may enhance
adipogenesis during adipose tissue expansion in response to high fat feeding, leading to a
more pronounced expansion of the stromal vascular compartment and a subsequent
increase in the number of adipose tissue macrophages, either through recruitment from
circulation or through local proliferation of the resident tissue monocyte/macrophage
population. This enhanced recruitment and/or proliferation of macrophages to/in the
adipose by DDE may not be deleterious on its own. However, this study found that DDE
can not only inhibit macrophage production of prostaglandins, which can initiate pro- and
anti-inflammatory feedback mechanisms, it can also alter gene expression of
macrophages that have received an activation stimulus, possibly interfering with their
overall polarization status. It is important to remember that all tissue macrophages do not
exist in a steady state of polarization or activation and can undergo phenotype switching
and, as shown by very recently published data, can even proliferate in their present
polarization state, given the appropriate stimulus. Accordingly, the ability of a polarized
macrophage to return to a resting, or inactive, state or appropriately repolarize towards an
alternative state under the direction of a new stimulus is equally important as the cell’s
response to its initial stimulus. Future investigations on DDE’s effects on macrophage
phenotype should involve more thorough characterization of the polarization state
following activation stimulus, through cytokine profiles and cell surface markers.
Furthermore, it would be valuable to know if DDE could affect the repolarization of
macrophages. It would be valuable to know if macrophages polarized in the presence of
DDE could fully repolarize to an alternative phenotype when given another stimulus, or if
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macrophages polarized without DDE could then switch phenotypes in the presence of the
organochlorine.
Still more future experiments might shed some light on the results of this study.
An investigation into the adipose tissue immune populations in Balb/c mice exposed to
DDE and a western-style diet from an early age (beginning at approximately 4 weeks of
age) could help determine if the effects of DDE on the SVF seen in the present study are
long lasting. However, a more relevant study might involve the characterization of the
SVF of human adipose tissue itself. Tissue samples could be obtained from biopsies
during surgery or as lipoaspirate obtained during lipoplasty, and would allow for the
isolation of both adipocytes and the SVF. This might allow us the opportunity to quantify
the amount of lipophilic compounds present in the adipose tissue itself and determine if
concentrations of any chemical or group of chemicals can affect the immune cell
population, as characterized by flow cytometry.
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3T3 EXPRESSION DATA, PROSTAGLANDIN DATA FROM THP-1 CELLS, AND
INITIAL FLOW CYTOMETRY EXPERIMENTAL RESULTS AND PROTOCOLS
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A.1

3T3 Terminal Differentiation Gene Expression
Eight days after the initiation of differentiation, total RNA was extracted using

Qiagen RNeasy Mini plus kit according to manufacturer’s directions. RNA extracts were
frozen at -80°C until such time that cDNA was generated using a Maxima first strand
cDNA synthesis kit (Thermo Scientific) according to manufacturer’s directions. cDNA
was stored at -80°C. Expression of fatty acid binding protein 4 (FABP4), peroxisome
proliferator activated receptor-γ (PPARγ), fatty acid synthase (FASn), sterol regulatory
element-binding protein 1c (SREBP1c), glucose transporter type 4 (Glut4), and leptin
(LEP) were analyzed in 3T3-L1 cells. β-actin (ACTB) was chosen as the reference gene
for terminal differentiation(1). Primer sequences are listed in Table 2.1.Two-step
quantitative real-time polymerase chain reaction (RT-qPCR) was performed on a
Stratagene MXP3005 using Taqman-based Luminaris Higreen low ROX qRT-PCR
reagents. Fold change in gene expression was estimated using the ΔΔCt method as
previously described (2, 3).

103

Figure A.1

Expression of terminal differentiation markers in 3T3 treatment groups
compared to sub-optimal vehicle.

Data (n=3) are expressed as mean fold change compared to sub-optimal vehicle +/standard error (SE). Differentiating 3T3 cells were exposed to increasing concentrations
of DDE (2.5, 10, and 20µM) or Vehicle (V; 0.05% ethanol) in a sub-optimal
differentiation cocktail for the first four days of differentiation. Full differentiation
(MIX; 95% differentiation) was achieved using 1mM dexamethasone, 500mM IBMX,
and 10 µg/mL human insulin. Eight days after the initiation of differentiation, cDNA was
synthesized from total RNA and quantified by RT-qPCR. Statistical significance was
determined by one-way ANOVA. Means with different symbols indicate significant
difference at P<0.05
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A.2
A.2.1

Prostaglandin Data
Macrophage cell culture
THP-1 monocytes were seeded at a density of 3.25x105cells/well on a 12-well

plate. THP-1 cells were induced to take on a macrophage conformation with 100nM
PMA for 48 hours before using in cell culture experiments. Induced cells were pretreated
for 18 hours in the presence of 20μM DDE or 10μM NS-398, followed by an immune
challenge of BSA (1%), LPS (250 ng/ml), or PA (200µM). Samples were collected at 4
and 6 hrs following immune challenge and cell culture supernatants were analyzed for
prostaglandin content by UPLC- ESI-MS/MS.
THP-1 macrophages were seeded onto 6 well plates at a density of 5x105 cells/ml
in RPMI containing 1 µg/ml LPS and incubated for 2 hours. Cells were scraped in 200µL
HBSS containing protease inhibitors and sonicated on ice. Cell lysate was added to PBS
containing DDE, 0.05% ethanol, or 10µM NS-398 then incubated in shaking water bath
for 15 minutes at 37°C. Following incubation, 10 µM AA was added to each tube.
Samples were vortexed vigorously and incubated for an additional 30 minutes at 37°C.
Tubes were placed on ice then centrifuged at 4°C to pellet cellular debris. Supernatant
was transferred to a new glass tube, extracted, and analyzed for prostaglandin production.
Arachidonic acid and prostacyclin levels in cell culture supernatant or from cell-free
supernatants were measured by UPLC- ESI-MS/MS. Briefly, internal standards were
added to supernatant and media was extracted using ethyl acetate and with 0.1% acetic
acid. Samples were mixed, centrifuged, and the resulting organic layer removed and dried
under nitrogen. Samples were resuspended in 1:1 water:methanol and transferred to a
glass vial with conical insert for analysis.
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Table A.1

Area ratios (analyte signal/internal standard signal) of secreted lipid
mediators by THP-1 macrophages 4 and 6 hours after LPS exposure (100
ng/mL). .

Mediator

PGE2

PGD2

PGF2α

AA

Time point 4 hours 6 hours 4 hours 6 hours 4 hours 6 hours 4 hours 6 hours
Vehicle

0.061

0.098

0.063

0.064

0.056

0.0553

2.243

2.284

20 μM
DDE

0.000

0.000

0.000

0.000

0.004

0.0092

1.646

2.656

Table A.2

Area ratios of lipid mediators secreted following 24 hour challenge of BSA
control or 200μM PA-BSA. Pretreaments: vehicle (EtOH) or 10μM DDE.

Challenge

BSA control

200μM PA-BSA

Mediator

AA

PGE2

TBX

AA

PGE2

TBX

EtOH

1.754

0.092

0.023

3.958

0.088

0.245

10μM DDE

1.753

0.126

0.024

3.396

0.020

0.096

106

Figure A.2

Prostaglandin secretion from THP-1 macrophages

THP-1 macrophages were pretreated with EtOH, 20µM DDE, or 10µM NS-398 for 18
hours. Cell were challenged with BSA, 0.25 µg/ml LPS, or 200µM PA-BSA.
Supernatants were harvested at 6 hours and analyzed for PGE2 content. DDE and NS-398
decreased basal and stimulated PGE2 production compared to vehicle control. Bars
represent fold decrease in prostaglandin detection by UPLC- ESI-MS/MS
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Figure A.3

Prostaglandin secretion from cell free system using THP-1 cells

THP-1 cells were differentiated with PMA, then administered 1 µg/mL LPS for 2 hours.
Cell lysates were generated and incubated with 0.05% EtOH, 20µM DDE or 10µM NS398 before the addition of 10µM AA. Generation of PG from AA by COX-2 was
measured by UPLC- ESI-MS/MS
A.3

Materials and Methods for Initial Flow Cytometry Experiments
The following methods describe the initial protocol for the isolation and

characterization of the immune cell populations in the stromal vascular fraction (SVF) in
C57Bl mice exposed to 2mg/kg DDE or corn oil vehicle for 5 days. Conclusions (A.3.6)
regarding the findings of this experiment and the explanation for changes made to the
final protocol are discussed in brief following the results section (A.3.5).
A.3.1

Animals
Male CD57BL/6J mice were obtained from Jackson Laboratories at 6 weeks of

age. All mice were housed under a 12-hour light-dark cycle and allowed free access to
food and water. The mice were housed in a university setting under standard conditions,
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and Institutional Animal Care and Use Committee (IACUC) approved protocols were
followed. At eight weeks of age, mice were considered sexually mature and
immunologically stable. To examine p,p’-DDE induced changes on the stromal vascular
fraction, mice were administered corn oil vehicle or p,p’-DDE (2 mg per kg body weight,
1 mg ml-1 solution) by oral gavage once per day for 5 days. Animals were sacrificed by
CO2 asphyxiation 12 hours after the fifth dose.
A.3.2

Isolation of the stromal vascular fraction
Following sacrifice, both epididymal white adipose tissue pads were collected and

transferred to a weigh boat containing 2 ml cold FACS-PBS composed of calcium and
magnesium free Dulbecco’s Phosphate Buffered Saline (DPBS, Invitrogen)
supplemented with 0.2% fatty acid free, low endotoxin BSA (Gemini Biotech).
Following isolation, adipose tissue digestion was performed using established protocols
with modifications (4, 5). Briefly, fat pads were minced finely (<10mg) and the
suspension was transferred to a 50ml centrifuge tube, followed by an additional rinse of
1.7ml FACS-PBS to collect remaining tissue. Purified collagenase (Worthington) was
added to each tube at a concentration of 200 units/ml and the solution was supplemented
with 0.5mM CaCl2 (Sigma). Suspensions were digested for 75 min at 37°C in a water
bath with gentle shaking. Following digestion, 12 ml cold FACS-PBS was added to each
sample and the digestate was passed through a 100µm mesh filter and centrifuged at 500
x g for 10 min at 4°C. Contaminating red blood cells in the resulting pellet were
removed using erythrocyte lysing buffer (BD Biosciences). The SVF was washed and
resuspended in FACS-PBS for immunostaining.
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A.3.3

Immunostaining and flow cytometry
The isolated SVF were stained with a combination of up to 3 directly conjugated

antibodies as previously described (5). Briefly, cells were incubated with Fc block (BD
Biosciences) to reduce non-specific staining, followed by direct surface staining for 20
min at room temperature in the dark using antibodies purchased from Thermo Scientific,
R&D Systems, or eBiosience. To identify SVF subpopulations, isolated cells were
incubated with one of three panels, summarized in Table A.3.
Table A.3

Staining panel for ATM

Cell population

Staining panel

CD3+CD4+CD8-/ CD3+CD4-CD8+

CD3E(FITC),CD4 (PE), CD8 (APC)

Foxp3 regulatory T cells

CD4 (FITC), CD25 (PE), Foxp3 (APC)

Macrophage cells

F4/80 (FITC), CD11b (APC)

CD4+CD8- and CD4-CD8+ T-cells were identified using surface markers CD3E
(Thermoscientific; 145-2C11), CD4 (Thermoscientific; GK1.5), and CD8
(Thermoscientific; 53-6.7). Macrophage/monocyte populations were identified using
CD11b (ThermoScientific; M1/70) and F4/80 (ThermoScientific; Cl:A3-1). Following
surface labeling, cells were washed once in FACS-PBS, resuspended in 400µl FACSPBS, and then stored at 4°C until analysis. In order to identify Foxp3+ T-regulatory cells,
the cells were first incubated with CD4 (R&D Systems; GK1.5) and CD25 (eBioscience;
PC61.5) for 20 min at room temperature in the dark, washed once with PBS. Stained cells
were then fixed and permeabilized using EBioscience Staining buffer set according to
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manufacturer’s protocol. Isolated cells were incubated in 1x fixation/permeabilization
solution for 30 minutes at 4°C in the dark, washed twice with 2ml permeabilization
buffer, then incubated with α-Foxp3 antibody (eBioscience; FJK-16s) or APC-conjugated
isotype control (eBioscience) for 30 minutes at 4°C in the dark. Cells were washed once
with permeabilization buffer, then resuspened in 400µl FACS-PBS. Samples were
analyzed immediately following staining using a FACScalibur flow cytometer (Beckton
Dickson) using a defined lymphocyte/macrophage gate.
A.3.4

Analysis
Analysis was conducted using FlowJo version 9.2 (TreeStar, Ashland, OR) using

histograms and dot plots. Comparisons between groups were conducted using Student’s ttest or one way ANOVA. Significance was designated as a p-value <0.05.
A.3.5
A.3.5.1

Results of initial flow cytometry analysis
p,p’-DDE exposure alters CD4+ lymphocyte subpopulations
Exposure to p,p’-DDE was associated with a significant decrease (p <0.05) in the

percentage of CD+ T-cells as compared with corn oil vehicle. The percentage of cells
derived from the CD3+ gate that stained positive for CD4 was 48% for corn oil exposed
mice and 38% in mice exposed to the treatment compound. There was not a significant
change in the number of CD8+ cells between vehicle and experimental mice, nor was
there a significant change in the ratio of CD4+/CD8+ between treatment groups.
Regarding T-regulatory cells, there was no significant change in the number of
CD4+CD25+Foxp3+ cells between treatment and experimental groups.
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A.3.5.2

Three possible subpopulations of CD11b+F4/80+ macrophage/monocytes
Analysis of CD11b+F4/80+ macrophage/monocyte populations revealed three

potential subsets of cells. All positive cells stained with approximately equal brightness
for F4/80, while the populations could be separated into CD11bDim, CD11bInt, and
CD11bBright with the later two appearing the same quadrant. A significant difference was
found in both the CD11bInt / CD11bBright and CD11bDim populations between vehicle and
experimental treatments. In control treated animals, CD11bInt / CD11bBright populations
accounted for an average of 41% of 10000 gated events, while CD11bDim accounted for
only 12%. Experimental treated animals exhibited a significant increase in the number of
CD11bDim cells, accounting for 20% of the total gated events while the percentage of
CD11bInt / CD11bBright cells fell to 35%. Unlike the lymphocyte panel, this shift in
staining was reflected in the ratio of CD11bInt / CD11bBright: CD11bDim cells; Control
treated animals exhibited a ratio of 3.5 CD11bInt / CD11bBright: CD11bDim while
experimental treated animals exhibited a ratio of 1.8. All differences observed in this
panel were significantly different (p<0.05). The percentage of double negative CD11bF4/80- cells and CD11b+F4/80- cells remained unchanged between the treatment groups.
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Figure A.4

Flow cytometric analysis of multiple immune cell populations

Flow cytometric analysis of the SVF from the epidydimal fat pads of C57BL/6J mice
administered control vehicle (corn oil) or p,p’-DDE by oral gavage over 5 days. The cell
populations of macrophages (F4/80+CD11b+), CD3+CD8+CD4- T cells, CD3+CD8CD4+ T cells, and CD4+CD25+Foxp3+ regulatory T cells were analyzed (n=5 mice in
each group, *p<0.05). Error bars represent S.E.M.
A.3.6

Conclusions from initial flow cytometry experiments
Initial follow-up experiments were intended to isolate the CD11b+F4/80+

macrophage populations for further testing using cell sorting techniques. After much
discussion and consultation of literature, a decision was made to add a viability stain to
further macrophage analysis to aid in doublet discrimination.
Initial experiments using the purified collagenase protocol revealed a surprising
and significant loss of viability of the stromal vascular fraction during the isolation and
digestion process. Apoptotic cells, especially macrophage cells, commonly form doublets
with other cells. The FACSCalibur machine lacks the capability for doublet
discrimination, making interpretation of the earlier data rather difficult. It is not possible
to completely eliminate the possibility that the CD11bhiF4/80+ populations were not
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contaminated with other leukocyte populations, most of which express CD11b. It was
determined that the “CD11blo/F4/80+ population was our macrophage population of
interest.
Ultimately, viability pilot studies revealed that long incubation times of the fat
pads on ice, required for the 5 sacrifices per morning, combined with the hour long
digestion time resulted in significant drops in viability (almost 80% loss of viability).
Two major changes arose from this viability pilot study. Firstly, it was determined
that no more than two mice per day could be processed per day in order. This drastically
reduced the amount of time that minced tissues incubated on ice. Secondly, it was
determined that collagenase type 4 digested the adipose tissue efficiently and completely,
within 25 minutes, without a loss in cell surface receptors, as was seen with collagenase
type 2, due to its low secondary enzymatic (low tryptic) activities. The finalized digestion
protocol as used for chapter IV is described below, followed by protocol descriptions for
the initial flow cytometry experiment.
A.3.7

Collagenase Type 4 Adipose Tissue Digestion for Flow Cytometry

Pre-digestion checklist
Digestion buffer: Sterile HBSS with Ca2+ and Mg2+ with 0.2% BSA (low-endotoxin,
FFA-free) with 1 mg/ml Worthington Collagenase type 4. Collagenase should be
prepared as a 10 mg/ml solution in digestion buffer and filter sterilized using a 0.22um
syringe filter.
Evening prior to digestion
o
o
o
o
o
o

Label 1 50mL centrifuge tube per sample (label both the tube and the cap)
Label 1 15ml round-bottom tube per sample (label both the tube and the cap)
Set out 1 100µM cell strainer for each sample
Label 2 small weigh boats per sample
Set out clean, sharp surgical supplies
Label 1 1.5ml microcentrifuge tube per sample
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Morning of flow cytometry run
o
o
o
o
o

Turn on centrifuge and set to 4°C. Set Acc to 9 and Dec to 1.
Turn on shaker bath and set to 37°C
Add ice to 2 coolers
Generate dry ice and place in chamber
Take 70% EtOH spray bottle to animal techniques room

Adipose tissue prep for flow cytometry
Materials
1ml sterile syringes
23 G sterile needles
50ml sterile conical bottom tubes
15ml sterile round-bottom tubes
Scissors and forceps
small weigh boats
Worthington collagenase type 4 (catalog number# LS004188, lot number 43E14252)
Collagenase 240 u/mg dw; Caseinase 175 u/mg dw; Clostripain 0.95 u/mg dw; Tryptic
0.03u/mg dw
10ml sterile serological pipettes
Sterile, plastic transfer pipettes
100µm cell strainers
Invitrogen DPBS (without Ca or Mg)
FACS buffer (Invitrogen DPBS with 0.2% BSA)
BD Pharm Lyse (1:10 Dilution in DI H20)
RPMI with 25mM HEPES
Digestion buffer (1x HBSS with 0.2% BSA ).

Methods Adipose tissue isolation and stromal-vascular fractionation adapted from (6)
1. Euthanize mice in a CO2 chamber.
2. Spray mouse with 70% ethanol.
3. Withdraw blood via cardiac puncture using a 1 ml syringe and 23 G needle
4. Remove needle from syringe and transfer whole blood to a labeled 1.5ml
microcentrifuge tube on ice.
5. Make a small incision in the skin using large, rounded, sterile scissors.
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6. Using scissors and forceps, carefully open peritoneal cavity and remove epididymal
fat pads and discard attached lymph nodes, if present. Transfer adipose tissue to a
weigh boat on ice and record total weight.
7. Transfer the adipose tissue to a 15ml round-bottom tube containing 7ml ice-cold
digestion buffer and, using clean scissors, mince tissue into fine (<5mm) pieces. Keep
samples on ice until all samples have been harvested. Work as quickly as possible.
8. Add 1ml of 10x Collagenase buffer to each tube, and then adjust final volume to 1
mg/ml with additional digestion buffer.
9. Incubate the adipose tissue in a shaking water bath for 30 minutes at 37°C, inverting
the tubes several times every 2-3 minutes.
10. After digestion is complete, add EDTA to a final concentration of 10mM and
incubate for an additional 5 minutes at 37°C, then place tubes on ice. Placing the
tubes on ice will reduce further collagenase activity.
11. While the samples are incubating, place a 100um nylon cell strainer over a labeled 50
ml conical tube and prewet with 5ml RPMI. Using a plastic transfer pipette, transfer
the bottom layer of the cell slurry onto the filter, followed by the adipocyte containing
upper layer. This step needs to be performed as rapidly as possible to ensure the
collagenase is neutralized quickly. If filtration is proceeding slowly for one sample,
place the pipette back in the digestion tube and move on to the next sample, returning
when the filter has drained. It is very easy to get samples out of order when this
occurs. It is imperative that ALL tubes are labeled clearly and kept in order at this
point; preferably, the digestion tube should be directly behind the 50mL collection
tube!
a. To aid filtration, apply gentle pressure to the nylon mesh with the tip of the
pipette when adding liquids. Otherwise, the liquid tends to pool in the filter
and drain slowly. It may be necessary to hold the filter slightly above the lip
of the conical tube to assist with drainage.
12. Rinse the digestion tube with 5ml RPMI and transfer to nylon filter. Wash the filter
twice using 5mL RPMI.
13. Centrifuge the cell suspensions for 7 minutes at 400xg at 4°C.
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14. Collect adipocytes using a transfer pipette and add to 700uL of RLT buffer and freeze
at -80 for PCR analysis. Gently aspirate the remaining supernatant.
15. Resuspend the SVF pellet in 0.5ml 1X BD Pharm Lyse, then gently vortex each tube.
This step is to lyse red blood cells.
16. Incubate on ice for 5 minutes in the dark, and then add at least 10ml ice-cold RPMI.
17. Centrifuge 400 x g for 5 minutes. Decant supernatant without disturbing the pellet.
18. Resuspend in 0.5ml serum/protein free PBS. Reserve 20µL for cell counts using
trypan blue.
A.3.8

ARIA PBMC Surface Marker Staining

1. Aliquot 500µL cell mixture (~ 5 x105 - 106 cells) from mouse fat pad preparations to
flow cytometry tubes w/ 35 uM cell strainer caps.
2. Wash by adding 3 mL serum/protein free PBS and centrifuge (400 x g for 5 min),
decant supernatant and gently break pellet (3 strikes). (Ensure brake is set to 1).
3. Resuspend pellet in 800µL serum/protein free PBS.
4. Add 1uL eFluor 780 to each tube and vortex immediately.
5. Incubate 30 minutes at 4°C in the dark. Count reserved cells during incubation.
6. Wash cells with 3mL FACS-PBS. Decant supernatant and break pellet (3 strikes).
7. Add 1.5 uL Fc Block (1 µg; BD#553142), vortex gently and incubate 7 minutes at
room temperature in the dark
8. Vortex CompBeads (BD # 552845) and label a separate tube for the following for
CompBead controls
a. CompBeads + PE-Cy7 (F4/80 ThermoScientific # MA5-16627 clone: CI:A31)
b. CompBeads + PE (CD11b ThermoScientific # MA1-10082; clone: M1/70)
c. CompBeads + APC (CD45 Biolegend # 103112; clone: 30-F11)
1. Add 100 uL of FACS-PBS buffer to each tube.
2. Add 1 drop (~ 60 uL) BD CompBeads to each tube and vortex.
3. Add 20 uL (based on titration) of each prediluted antibody
stock (diluted to an optimal concentration for staining 106
cells) to the appropriately labeled tube.
4. Add 100µL FACS-PBS to an additional tube labeled “negative
comp beads.” Add 1 drop (~60µL) Negative BD CompBeads
and vortex.
5. Incubate 20 minutes at RT, in the dark.
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6. Proceed to step #10
9. Add antibodies, vortex lightly, and incubate for 30 minutes in the dark at 4°C.
a. CD45; F4/80; CD11b panel (each sample)
i. 5 uL (0.5 µg) CD11b (PE) ThermoScientific # MA1-10082; clone:
M1/70
ii. 2.5 uL (0.5 µg) F4/80 (PE-Cyanine7) eBioscience # 25-4801; clone:
BM8
iii. 1.5 uL (0.25 µg) CD45 (APC) Biolegend # 103112; clone: 30-F11
b. FMO CD45; F4/80
i. 5 uL (0.5 µg) CD11b (PE) ThermoScientific # MA1-10082; clone:
M1/70
ii. 1.5 uL (0.25 µg) CD45 (APC) Biolegend # 103112; clone: 30-F11
c. FMO CD45; CD11b
i. 2.5 uL (0.5 µg) F4/80 (PE-Cyanine7) eBioscience # 25-4801; clone:
BM8
ii. 1.5 uL (0.25 µg) CD45 (APC) Biolegend # 103112; clone: 30-F11
10. Wash by adding 3 mL FACS-PBS and centrifuge (400 x g for 5 min), decant
supernatant and break pellet.
11. Resuspend in 400 uL FACS-PBS containing 50 µg/ml DNase I and 2mM MgCl2
Sort preparation using Qiagen RNeasy Plus RNA extraction kit
12. Add 500µL RLT Plus buffer to 1, sterile 1.5ml microcentrifuge tube.
13. Sort cells directly into RLT buffer.
14. Following sort, measure exact final volume using a sterile, RNase free pipette tip.
15. Calculate the amount of buffer added to RLT during the sort.
16. Add additional RLT buffer so that there is exactly 350µL of RLT for every 100µL of
sorted sample volume.
17. Pipette sample gently to mix.
18. Add 250uL of 100% EtOH for every 350uL-100 of RLT-Sample volume (250µl
ethanol for every 450µL of final sample volume).
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19. Mix sample and apply directly to RNeasy mini column in 700µL aliquots, discarding
flow-through.
20. Follow directions for isolation as per manufacturer’s directions.
A.3.9

Stromal Vascular Fraction Isolation Using Purified Collageanse

Pre-digestion checklist
Sterile FACS-PBS with .2% BSA (in 250ml bottle) and sterile FACS-PBS with .4% BSA
and 10mM CaCl2 (50ml centrifuge tube) is premade and in the upright refrigerator in the
cell culture room
Evening prior to digestion
o Label 2 50mL centrifuge tubes
o 1 tube for digestion
o 1 tube for 10ml sterile FACS-PBS
o Set out 1 100µM cell strainer for each sample
o Label 1 small weigh boat per sample
o Set out clean, sharp surgical supplies
Morning of flow cytometry run
o
o
o
o
o
o

Turn on centrifuge and set to 4°C. Set Acc to 9 and Dec to 0.
Turn on shaking water bath and set to 37°C
Add ice to a large cooler
Generate dry ice and place in chamber
Take 70% EtOH spray bottle to animal techniques room
Thaw one .250 ml aliquot of purified collagenase/ sample
o Each aliquot contains 800u/ml in FACS PBS
o Dilute aliquot into 1.75ml FACS PBS containing 10mM CaCl2

Adipose tissue prep for flow cytometry
Materials
1ml sterile syringes
23 G sterile needles
EDTA microtainer for blood
50ml conical bottom tubes
Sterile scissors and forceps
large weigh boats
Worthington purified collagenase
10ml serological pipettes
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100µm cell strainer
Invitrogen DPBS (without Ca or Mg)
FACS buffer (Invitrogen DPBS with 0.2% BSA)
BD Pharm Lyse
Digestion buffer (1x DPBS with 0.2% BSA, 10mM CaCl2 ).
1. Euthanize mice in a CO2 chamber and withdraw blood via cardiac puncture using a 1
ml syringe and 21 G needle
2. Remove needle from syringe and transfer whole blood to labeled EDTA tube.
3. Spray peritoneum with 70% ethanol
4. Carefully open peritoneal cavity and remove epididymal fat pads and remove lymph
nodes, if present. Weigh fat pads.
5. Transfer adipose tissue to a weigh boat containing 2 ml DPBS and keep on ice.
6. Mince tissue into fine (<5mg) pieces.
7. Transfer the adipose tissue to a 10ml round-bottom tube by pouring the minced tissue
and DPBS into the tube.
8. Follow transfer by rinsing the weigh boat with 2 ml of the pre-prepared collagenase
solution. (Total collagenase concentration is now 200u/ml, 0.2% BSA).
9. Incubate the adipose tissue on a shaker for 30 minutes at 37°C. Invert tubes several
times every 2 minutes, shaking vigorously every 10 minutes.
10. After digestion is complete, add EDTA to a final concentration of 1mM and incubate
for an additional 10 minutes.
11. Place a 100µm cell strainer over the mouth of each tube containing the ice cold FACS
PBS and transfer the digested solution to the new 50ml conical bottom tube. Pipette
bottom fraction of cell solution through filter first, followed by upper layer. Wash
each filter twice with 10ml FACS PBS
12. Centrifuge the cell suspensions for 10 minutes at 500xg at 4°C.
13. Pour off the supernatant and resuspend the SVF pellet in 1 ml 1X BD Pharm Lyse,
then gently vortex each tube. This step is to lyse red blood cells.
14. Incubate at room temperature for 5 minutes.
15. Centrifuge 500 x g for 10 minutes, then carefully aspirate supernatant without
disturbing the pellet.
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16. Resuspend in 4.1ml DPBS containing 0.2% BSA
A.3.10 PBMC Surface Marker Staining for FACS Calibur
1. Aliquot 500 µL cell mixture (~ 5 x105 - 106 cells) from mouse fat pad preparations to
flow cytometry tubes w/ 35 uM cell strainer caps.
Include one extra tube for cells only control.
2. Wash by adding 3 mL FACS-PBS and centrifuge (400 x g for 7 min), aspirate
supernatant and break pellet. (Ensure brake is turned off on centrifuge).
3. Add 2 uL Fc Block (1 ug; BD#553142) incubate 7 minutes at room temperature
4. Vortex CompBeads (BD # 552845) and label a separate tube for the following for
CompBead controls
a. CompBeads + FITC (CD3 ThermoScientific # MA1-21174 clone:145-2C11)
b. CompBeads + PE (CD4 ThermoScientific # MA1-10220 clone: GK1.5)
1. Add 100 µL of FACS-PBS buffer to each tube.
2. Add 1 drop (~ 60 µL) BD CompBead negative control and 1
drop BD CompBeads (~ 60 µL) to each tube and vortex.
3. Add 20 uL (based on titration) of each prediluted antibody
stock (diluted to an optimal concentration for staining 106
cells) to the appropriately labeled tube.
4. Vortex gently and incubate 20 minutes at RT, in the dark.
5. Proceed to step #6
5. Add antibodies, vortex lightly, and incubate for 20 minutes in the dark at RT.
a. CD3 CD4 CD8 panel
i. 10 µL (1 µg) CD3 (FITC) ThermoScientific # MA1-21174 clone:1452C11,
ii. 6 µL (3 µg) CD4 (PE) ThermoScientific # MA1-10220 clone: GK1.5,
iii. 30 µL (3 µg) CD8 (APC) ThermoScientific # MA1-10302 clone: 536.7
b. F4/80 CD11b panel
i. 5 µL (0.5 µg) CD11b (PE) ThermoScientific # MA1-10082 clone:
M1/70,
ii. 12.5 µL (1.25 µg) F4/80 (FITC) ThermoScientific # MA5-16627
clone: CI:A3-1)
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6. Wash by adding 3 mL FACS-PBS and centrifuge (400 x g for 7 min), aspirate
supernatant and break pellet
7. Resuspend in 400 µL FACS-PBS
A.3.11 Mouse Tregs Staining Protocol:
1. Follow adipose tissue digestion and stromal vascular fraction (SVF) isolation protocol
to obtain immune cell fraction. Red blood cells will be lysed during this protocol.
500 µL of cells will be in each sample tube.
2. Wash by adding 3 mL FACS-PBS and centrifuge (400 x g for 7 min), aspirate
supernatant and break pellet. (Ensure brake is turned off on centrifuge).
3. Add 2 µL Fc Block (1 µg; BD#553142) incubate 7 minutes at room temperature
4. Add the appropriate amount of antibodies or PBS (cells only) to each tube ((5
(experimental) + 4 (control) = 9 tubes)).
α-CD4 (FITC)= 20 l (0.5 µg) (R&D Systems #FAB554F; Clone =
GK1.5)
α-CD25 (PE) = 1 l (0.2 µg) (eBioscience # 12-0251, Clone= PC61.5)
 Controls
2 tubes with cells only (no antibody)
1 tube with 10 µL α-CD3 (FITC) only (COMP BEADS)
1 tube with 6 µL α-CD4 (PE) only (COMP BEADS)
1 tube with α-CD4 + α-CD25 (FITC+PE)
1 tube with α-CD4 + α-CD25 (FITC+PE) for APC-Conjugated Isotype
Control to be added later.
Incubate for 20 minutes in the dark at RT.
5. Wash by adding 3 mL FACS-PBS and centrifuge (400 x g for 7 min), aspirate
supernatant and break pellet
α-FOXP3 Protocol = (Ebioscience Staining Buffer Set # 00-5523)
6. Add 1 ml Fixation/ Permeabilization (FP) Solution (made from 4X stock FP
Concentrate in FP Diluent) to ALL tubes and vortex
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Make enough for 5 (experimental) + 4 (control) + 1 (extra) = 10 tubes: add
2.50 mL 4X Fixation/ Permeabilization Concentrate to 7.5 mL Fixation/
Permeabilization Diluent and mix.

7. Incubate in the dark on ice for 30 min
8.

9.

Wash by adding 2 ml 1X Permeabilization Buffer (made from 10X buffer diluted in
distilled water), and centrifuge 400 g x 7 min. Aspirate supernatant and break pellet.


Make enough for 3 washes. Therefore: 3 washes/tube x 2 mL/ wash x 10
tubes = 60 mL total. Add 6 mL 10X Permeabilization Buffer to 54 mL DI
H2O for a total of 60 mL 1X Permeabilization Buffer.



NOTE: this makes enough extra 1X Permeabilization Buffer to use in step
number 10.

REPEAT #8 (Wash)

10. Add 5 µL APC- conjugated α-FOXP3 antibody (or Isotype Control) in 150 µL 1X
Permeabilization Buffer and incubate on ice for 30 min in the dark





Add 5 µL APC- conjugated α-FOXP3 (eBioscience #17-5773; clone = FJK16s)
Add 5 µL APC-conjugated isotype control antibody to isotype control tube
(eBioscience # 17-4321; clone = eBR2a)
Q.S. to 150 µL 1X Permeabilization Buffer
ADD ANTIBODY ONLY TO EXPERIMENTAL & ISOTYPE
CONTROL TUBES (NOT OTHER CONTROLS)

11. REPEAT #8 (Wash)
12. Resuspend pellet in 400 l of FACS-PBS
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Table A.4

Reagent list for initial flow cytometry experiments
Name

Company

Dubelco’s Phosphate Buffered Saline

Catalog No.

Invitrogen

Collagenase type II

Worthington

Rat anti-mouse CD16/CD32

BD Biosciences

553142

BD compbead anti-rat/hamster

BD Biosciences

552845

BP Pharm Lyse

BD Biosciences

555899

Foxp3 staining buffer set

eBioscience

00-5523

Rat anti-mouse CD25

eBioscience

12-0251-82

Rat anti-mouse Foxp3

eBioscience

17-5773-82

Rat anti-mouse CD4

Thermo Scientific

MA1-81179

Rat anti-mouse F4/80

Thermo Scientific

MA5-16627

Rat anti-mouse CD11b

Thermo Scientific

MA1-10082

Rat anti-mouse CD8a

Thermo Scientific

MA1-10302

Rat anti-mouse CD4

Thermo Scientific

MA1-10220

Hamster anti-mouse CD3E

Thermo Scientific

MA1-21174
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